Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,A1BG,Alpha-1B-glycoprotein,40679,105,3.86 [1.22-12.23],0.021733092334743
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ABCA2,ATP-binding cassette sub-family A member 2,39283,102,2.96 [2.08-4.21],1.7134936506637915e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ABL1,Tyrosine-protein kinase ABL1,46483,124,1.39 [1.12-1.73],0.0024741936351694
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",45615,120,1.64 [1.39-1.93],4.787922592291903e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACAN,Aggrecan core protein,46256,124,0.54 [0.30-0.96],0.0368637427652414
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACE,Angiotensin-converting enzyme,40646,105,2.92 [1.59-5.35],0.0005183781883831
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACE2,Angiotensin-converting enzyme 2,45838,124,1.87 [1.50-2.34],3.6280445566353874e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACP1,Low molecular weight phosphotyrosine protein phosphatase,39446,103,0.63 [0.40-1.00],0.048451398508407
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACP5,Tartrate-resistant acid phosphatase type 5,46891,128,2.88 [2.13-3.89],7.504689207218237e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACRV1,Acrosomal protein SP-10,39446,103,1.26 [1.05-1.53],0.0156792292743392
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACTA2,"Actin, aortic smooth muscle",45838,124,2.21 [1.83-2.67],1.3548336717330802e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACTN2,Alpha-actinin-2,39283,102,1.64 [1.28-2.08],6.759316565702853e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACVRL1,Serine/threonine-protein kinase receptor R3,46258,124,6.80 [4.95-9.35],2.7564297449054244e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACY1,Aminoacylase-1,46694,125,1.91 [1.53-2.38],8.344806375970616e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,39283,102,2.13 [1.62-2.81],8.541176115711388e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADA2,Adenosine deaminase 2,46431,124,6.29 [4.90-8.07],3.1497180253023576e-47
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,45838,124,1.97 [1.18-3.26],0.0089244830543556
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,46337,124,1.76 [1.15-2.68],0.0092078216483052
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,47210,127,1.96 [1.21-3.17],0.0062325827678772
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,47039,128,2.77 [1.92-4.00],5.6740633650179735e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,40451,106,4.70 [3.40-6.50],8.414995659179207e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,39446,103,2.43 [1.79-3.31],1.5741846844600653e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,46483,124,2.74 [1.92-3.91],2.6860688062710512e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,39446,103,2.00 [1.33-3.02],0.0009547057311437
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,46850,129,0.63 [0.45-0.88],0.0075677065745032
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAMTSL2,ADAMTS-like protein 2,40614,105,6.51 [4.80-8.84],2.769314286405118e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAMTSL5,ADAMTS-like protein 5,40628,107,1.65 [1.10-2.47],0.0156621200996219
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADGRB3,Adhesion G protein-coupled receptor B3,46258,124,3.33 [2.13-5.21],1.3638209714264457e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADGRD1,Adhesion G-protein coupled receptor D1,39729,105,2.67 [1.77-4.05],3.274469772605767e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADGRE1,Adhesion G protein-coupled receptor E1,40451,106,2.10 [1.57-2.82],6.218760458445979e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADGRE2,Adhesion G protein-coupled receptor E2,46900,124,7.64 [4.95-11.80],4.543842996358484e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADGRE5,Adhesion G protein-coupled receptor E5,47034,127,4.33 [3.40-5.50],8.387573729207301e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADGRF5,Adhesion G protein-coupled receptor F5,40628,107,2.71 [1.39-5.27],0.0033228675521362
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADGRG1,Adhesion G-protein coupled receptor G1,46483,124,2.31 [2.03-2.63],9.333356486667236e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADGRG2,Adhesion G-protein coupled receptor G2,46694,125,0.40 [0.31-0.51],1.4065629738123297e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADIPOQ,Adiponectin,40679,105,0.66 [0.50-0.87],0.0030252758304894
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADM,Pro-adrenomedullin,47097,128,30.78 [16.91-56.04],3.646023820412472e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AFP,Alpha-fetoprotein,46184,124,0.58 [0.44-0.75],5.064908203471218e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AGR2,Anterior gradient protein 2 homolog,45260,123,2.01 [1.76-2.29],3.189200419827461e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AGR3,Anterior gradient protein 3,45538,120,1.56 [1.26-1.95],6.740562773102053e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AGRN,Agrin,46900,124,3.95 [3.23-4.84],1.770982298178391e-40
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AGRP,Agouti-related protein,47210,127,2.58 [1.99-3.36],1.6433033421137622e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AGT,Angiotensinogen,40646,105,1.90 [1.00-3.60],0.0498829839824839
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AGXT,Serine--pyruvate aminotransferase,46694,125,1.64 [1.36-1.97],1.870832203925515e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AHNAK2,Protein AHNAK2,39538,103,2.05 [1.20-3.48],0.0081917269552783
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AHSP,Alpha-hemoglobin-stabilizing protein,46621,127,0.80 [0.66-0.96],0.0172650107792149
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AIF1L,Allograft inflammatory factor 1-like,39538,103,1.33 [1.02-1.74],0.0378846970469054
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",46405,124,1.30 [1.13-1.49],0.0002907812045629
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AK1,Adenylate kinase isoenzyme 1,46694,125,0.61 [0.47-0.80],0.0002457018913641
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AKR1B10,Aldo-keto reductase family 1 member B10,39492,104,1.55 [1.26-1.91],2.924938416873456e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AKR7L,Aflatoxin B1 aldehyde reductase member 4,39446,103,1.46 [1.17-1.83],0.0008010998231279
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ALCAM,CD166 antigen,47267,128,12.99 [6.97-24.23],7.25539022931015e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",46552,123,1.32 [1.11-1.57],0.0014848771308855
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",40550,105,1.72 [1.25-2.38],0.0009350620133461
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ALMS1,Alstrom syndrome protein 1,39882,107,1.45 [1.06-2.00],0.0217074707716545
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ALPP,"Alkaline phosphatase, placental type",46483,124,1.25 [1.08-1.45],0.0023861265706434
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AMBP,Protein AMBP,47028,128,25.64 [14.56-45.15],2.67958595202354e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AMIGO2,Amphoterin-induced protein 2,46483,124,5.38 [3.05-9.51],6.583819710997586e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AMY2A,Pancreatic alpha-amylase,44899,121,0.69 [0.49-0.96],0.0284230742679782
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AMY2B,Alpha-amylase 2B,43523,116,0.60 [0.43-0.85],0.0039857392090143
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANG,Angiogenin,46575,125,2.56 [1.77-3.70],6.725281168636901e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANGPT2,Angiopoietin-2,47097,128,5.57 [4.07-7.64],1.0872288556707303e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANGPTL1,Angiopoietin-related protein 1,46024,125,4.66 [2.76-7.86],7.862715874901394e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANGPTL2,Angiopoietin-related protein 2,46746,123,2.04 [1.39-2.99],0.0002396841611913
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANGPTL3,Angiopoietin-related protein 3,46731,125,0.59 [0.37-0.92],0.0207878413342117
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANGPTL4,Angiopoietin-related protein 4,46823,124,5.19 [3.70-7.29],1.884306989010535e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANGPTL7,Angiopoietin-related protein 7,47097,128,3.47 [2.63-4.59],2.423050037061432e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANKRD54,Ankyrin repeat domain-containing protein 54,45615,120,0.72 [0.52-1.00],0.0466033615087873
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANXA10,Annexin A10,45638,124,1.50 [1.28-1.75],3.73664450333707e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANXA5,Annexin A5,45485,123,2.32 [1.52-3.56],0.0001040587859829
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AOC1,Amiloride-sensitive amine oxidase [copper-containing],45833,124,0.66 [0.45-0.95],0.0256253832023033
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AOC3,Membrane primary amine oxidase,46888,125,11.86 [7.95-17.71],1.0120476451933348e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AP1G2,AP-1 complex subunit gamma-like 2,40433,105,1.30 [1.04-1.62],0.0191648303334602
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AP3B1,AP-3 complex subunit beta-1,40451,106,1.34 [1.08-1.68],0.0095121189866682
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AP3S2,AP-3 complex subunit sigma-2,40529,106,1.43 [1.03-1.97],0.0310511262025768
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APCS,Serum amyloid P-component,40320,105,0.46 [0.27-0.79],0.0044231955010718
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APLP1,Amyloid-like protein 1,46694,125,0.49 [0.36-0.68],1.3948078132638366e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APOA1,Apolipoprotein A-I,40679,105,0.47 [0.32-0.69],0.0001542928997745
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APOA4,Apolipoprotein A-IV,40679,105,3.44 [2.73-4.33],8.475119795829328e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APOBR,Apolipoprotein B receptor,39538,103,0.55 [0.37-0.83],0.0037608934516788
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APOC1,Apolipoprotein C-I,40604,105,0.49 [0.37-0.65],9.4659521840646e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APOD,Apolipoprotein D,38841,103,0.60 [0.45-0.79],0.0002248745249007
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APOF,Apolipoprotein F,40646,105,0.40 [0.30-0.55],1.1595777403980056e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APOL1,Apolipoprotein L1,40646,105,0.55 [0.37-0.81],0.0029796768691059
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APOM,Apolipoprotein M,46810,125,0.31 [0.23-0.43],1.4669012828648814e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AREG,Amphiregulin,46483,124,4.59 [3.79-5.56],3.794844061776064e-55
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARG1,Arginase-1,46427,126,0.55 [0.41-0.75],0.0001494643570865
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARHGAP1,Rho GTPase-activating protein 1,45615,120,0.65 [0.46-0.92],0.0163394317233853
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARHGEF10,Rho guanine nucleotide exchange factor 10,40550,105,1.22 [1.01-1.48],0.0371128116241483
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARHGEF5,Rho guanine nucleotide exchange factor 5,39312,102,1.46 [1.19-1.79],0.0002785923727451
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARID4B,AT-rich interactive domain-containing protein 4B,45638,124,0.54 [0.33-0.90],0.0184252341439553
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ART3,Ecto-ADP-ribosyltransferase 3,46888,125,1.98 [1.31-2.99],0.0012300256228638
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ASAH1,Acid ceramidase,40229,105,1.61 [1.26-2.05],0.0001411080370399
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ASGR1,Asialoglycoprotein receptor 1,46337,124,7.06 [5.34-9.32],4.1765944585458445e-43
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ASGR2,Asialoglycoprotein receptor 2,40646,105,6.52 [3.67-11.61],1.734319231253926e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ASPN,Asporin,40628,107,1.79 [1.13-2.84],0.0127327712805393
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATG16L1,Autophagy-related protein 16-1,40451,106,1.30 [1.05-1.61],0.0142766299305984
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATOX1,Copper transport protein ATOX1,46850,129,1.36 [1.08-1.71],0.0081066659595817
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,39283,102,1.37 [1.07-1.74],0.0109067091156748
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATP6AP2,Renin receptor,45615,120,1.84 [1.43-2.36],1.7798189273824443e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATRAID,All-trans retinoic acid-induced differentiation factor,40451,106,1.79 [1.49-2.15],3.2339503196872184e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATRN,"Attractin, Isoform 2",40679,105,5.39 [1.94-14.94],0.001215544700244
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AXL,Tyrosine-protein kinase receptor UFO,46888,125,4.08 [2.44-6.81],8.393901681114093e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,B2M,Beta-2-microglobulin,40679,105,2.00 [1.72-2.32],5.479199834709823e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",39538,103,8.82 [5.68-13.72],3.913955064795973e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,B4GALT1,"Beta-1,4-galactosyltransferase 1",46900,124,8.58 [5.54-13.28],6.054543265832248e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BACH1,Transcription regulator protein BACH1,46626,123,1.30 [1.06-1.60],0.0133879159759554
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BAG4,BAG family molecular chaperone regulator 4,39446,103,1.59 [1.15-2.19],0.0052290540585038
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,45615,120,1.83 [1.53-2.19],2.491846688184929e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BAMBI,BMP and activin membrane-bound inhibitor homolog,45615,120,3.65 [2.80-4.76],1.6324633357594969e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BCAM,Basal cell adhesion molecule,46698,127,3.26 [2.17-4.90],1.2925686764754892e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BCAN,Brevican core protein,46337,124,0.37 [0.29-0.48],4.990643357057713e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",39312,102,0.53 [0.32-0.87],0.0120928332804721
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BCL2,Apoptosis regulator Bcl-2,40451,106,1.52 [1.21-1.90],0.0002885949803601
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",46626,123,2.54 [1.63-3.96],3.98564555702783e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BCL2L15,Bcl-2-like protein 15,39446,103,1.33 [1.00-1.76],0.0460788461273081
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BCL7B,B-cell CLL/lymphoma 7 protein family member B,40433,105,0.57 [0.34-0.97],0.0386366596117561
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BCR,Breakpoint cluster region protein,46626,123,1.23 [1.03-1.46],0.0194221423046767
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BGLAP,Osteocalcin,40614,105,0.68 [0.55-0.84],0.0002831228572809
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BLMH,Bleomycin hydrolase,47267,128,0.58 [0.37-0.92],0.0207885008273081
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BLVRB,Flavin reductase,46698,127,0.74 [0.57-0.95],0.0176530182234453
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BMP10,Bone morphogenetic protein 10,39729,105,3.58 [1.82-7.02],0.0002111261264797
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BMP4,Bone morphogenetic protein 4,46258,124,1.39 [1.02-1.88],0.0368280345200812
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BMP6,Bone morphogenetic protein 6,45762,124,1.59 [1.09-2.32],0.0166040695204826
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BMPER,BMP-binding endothelial regulator protein,39729,105,7.45 [5.21-10.64],3.306547417174873e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,39446,103,2.21 [1.60-3.06],1.6638565431787505e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BOC,Brother of CDO,45838,124,6.97 [3.92-12.41],3.929371893761431e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BOLA2_BOLA2B,BolA-like protein 2,39538,103,0.66 [0.47-0.95],0.0238866013128364
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BPIFA2,BPI fold-containing family A member 2,38117,100,0.83 [0.69-0.99],0.0406245152024167
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BPIFB1,BPI fold-containing family B member 1,46588,125,0.79 [0.62-1.00],0.049791824453097
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BRSK2,Serine/threonine-protein kinase BRSK2,40550,105,1.58 [1.06-2.35],0.0256706216742606
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BSG,Basigin,47133,127,8.14 [4.57-14.49],1.0466684555763076e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,47117,128,2.87 [1.69-4.88],9.952624595861854e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BST2,Bone marrow stromal antigen 2,47117,128,1.62 [1.30-2.02],1.7609437278323296e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BTD,Biotinidase,40679,105,3.37 [1.31-8.64],0.011451291308183
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BTN2A1,Butyrophilin subfamily 2 member A1,46900,124,6.98 [4.99-9.77],9.53963268525568e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BTN3A2,Butyrophilin subfamily 3 member A2,46626,123,2.22 [1.79-2.76],4.3348191960439723e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C1GALT1C1,C1GALT1-specific chaperone 1,39283,102,1.57 [1.00-2.46],0.0496153640560218
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C1QA,Complement C1q subcomponent subunit A,46978,126,4.99 [2.84-8.76],2.1052480192053653e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C1QL2,Complement C1q-like protein 2,39446,103,0.60 [0.38-0.94],0.024760799105626
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,46888,125,3.03 [2.38-3.86],2.344394266990342e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,39729,105,1.89 [1.13-3.16],0.0149216514688943
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,40550,105,1.58 [1.01-2.47],0.0460003301090444
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C1RL,Complement C1r subcomponent-like protein,40609,105,5.97 [2.26-15.79],0.0003201595064959
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C2,Complement C2,46810,125,7.18 [3.40-15.19],2.471911242932267e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C2CD2L,Phospholipid transfer protein C2CD2L,45562,123,1.54 [1.18-2.02],0.0016853929480075
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C5,Complement C5,40679,105,3.21 [1.07-9.62],0.0372572942458118
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C7,Complement component C7,39701,103,12.09 [8.34-17.52],1.4363331256049084e-39
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C9orf40,Uncharacterized protein C9orf40,40451,106,0.75 [0.59-0.95],0.0179539905978603
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA1,Carbonic anhydrase 1,45645,122,0.58 [0.43-0.76],0.0001112366747477
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA11,Carbonic anhydrase-related protein 11,45615,120,1.73 [1.26-2.39],0.0007557519939362
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA12,Carbonic anhydrase 12,46483,124,4.64 [3.70-5.81],9.061252771950735e-41
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA2,Carbonic anhydrase 2,46543,127,0.69 [0.54-0.88],0.0027549684105143
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA3,Carbonic anhydrase 3,47189,127,1.35 [1.06-1.73],0.0152280312539647
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA5A,"Carbonic anhydrase 5A, mitochondrial",45838,124,1.44 [1.24-1.67],2.0368502328889054e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA6,Carbonic anhydrase 6,46560,127,0.52 [0.40-0.66],2.0160085039777585e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA9,Carbonic anhydrase 9,47097,128,2.43 [1.87-3.16],2.983952952113179e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,40550,105,1.27 [1.03-1.58],0.0276033147230301
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CALB1,Calbindin,46483,124,1.57 [1.12-2.19],0.0082833842048715
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CALCA,Calcitonin,46261,123,1.77 [1.49-2.10],9.762671870659759e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CALCB,Calcitonin gene-related peptide 2,40529,106,1.75 [1.27-2.41],0.0005841005562129
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,45615,120,1.47 [1.06-2.04],0.0217901603219244
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CANT1,Soluble calcium-activated nucleotidase 1,46556,125,8.68 [4.26-17.68],2.5868052552038795e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CAPG,Macrophage-capping protein,46355,127,1.40 [1.09-1.80],0.0092406669791227
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CARHSP1,Calcium-regulated heat-stable protein 1,45638,124,0.50 [0.36-0.71],7.543347595686249e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CASP8,Caspase-8,46960,128,0.72 [0.55-0.94],0.0175603290573956
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CAT,Catalase,40042,102,0.59 [0.41-0.87],0.0075006121742105
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CBLIF,Cobalamin binding intrinsic factor,46621,125,1.62 [1.33-1.97],2.015502144523894e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCDC80,Coiled-coil domain-containing protein 80,46694,125,2.69 [1.91-3.78],1.3878888380520637e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL11,Eotaxin,47210,127,3.55 [2.34-5.39],2.654459345306535e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL14,C-C motif chemokine 14,46575,125,1.92 [1.48-2.50],1.0155165294595556e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL15,C-C motif chemokine 15,47267,128,4.12 [3.12-5.45],1.652791559330117e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL16,C-C motif chemokine 16,47267,128,2.61 [1.92-3.54],9.62648476363658e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL18,C-C motif chemokine 18,46047,124,1.21 [1.01-1.45],0.0415094919123569
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL19,C-C motif chemokine 19,47117,128,1.15 [1.03-1.27],0.0101025983093466
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL20,C-C motif chemokine 20,47210,127,1.55 [1.37-1.75],1.1794106584207417e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL21,C-C motif chemokine 21,46900,124,2.18 [1.80-2.64],3.129418638705856e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL22,C-C motif chemokine 22,46214,123,1.58 [1.20-2.08],0.001203520596008
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL23,C-C motif chemokine 23,46900,124,1.80 [1.24-2.61],0.0019263132039259
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL25,C-C motif chemokine 25,47210,127,2.70 [1.99-3.65],1.2791530778826535e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL28,C-C motif chemokine 28,46477,123,1.46 [1.15-1.86],0.0020453868235659
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL3,C-C motif chemokine 3,46626,123,1.42 [1.23-1.65],2.0845083521939383e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL7,C-C motif chemokine 7,46626,123,1.70 [1.44-2.01],3.060039388109754e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCN1,CCN family member 1,46405,124,1.42 [1.13-1.79],0.0028269238624734
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCN3,CCN family member 3,47196,128,3.50 [2.59-4.74],4.051331507319435e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCN4,CCN family member 4,47097,128,3.35 [2.49-4.51],1.5555119686925797e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCN5,CCN family member 5,46698,127,3.31 [2.31-4.74],6.392550784150883e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCS,Copper chaperone for superoxide dismutase,46337,124,0.41 [0.29-0.59],1.937491976501768e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD101,Immunoglobulin superfamily member 2,40451,106,1.70 [1.11-2.63],0.0156613391545699
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD109,CD109 antigen,46698,127,4.12 [2.60-6.52],1.632045376571848e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD14,Monocyte differentiation antigen CD14,45736,125,3.25 [2.39-4.43],7.498895840945535e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD160,CD160 antigen,47210,127,3.12 [2.43-4.01],3.993878084574971e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD163,Scavenger receptor cysteine-rich type 1 protein M130,46888,125,2.75 [2.01-3.76],1.9305853559824084e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD164,Sialomucin core protein 24,46698,127,1.76 [1.46-2.13],4.85291198352942e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD1C,T-cell surface glycoprotein CD1c,46850,129,0.49 [0.34-0.71],0.0001574420830718
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD2,T-cell surface antigen CD2,39283,102,1.61 [1.22-2.12],0.0006885835905518
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD200,OX-2 membrane glycoprotein,46626,123,2.31 [1.43-3.72],0.0006156218121409
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD200R1,Cell surface glycoprotein CD200 receptor 1,46474,122,1.61 [1.03-2.50],0.0353175945549783
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD207,C-type lectin domain family 4 member K,45679,121,3.52 [2.40-5.16],1.338431560706963e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD22,B-cell receptor CD22,47210,127,1.82 [1.35-2.46],9.9898398548864e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD226,CD226 antigen,39446,103,1.77 [1.17-2.68],0.0070459280681059
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD244,Natural killer cell receptor 2B4,47210,127,4.57 [2.85-7.33],2.722119391504789e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD248,Endosialin,40614,105,0.55 [0.34-0.88],0.0117811953878387
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD27,CD27 antigen,46850,129,4.32 [3.55-5.26],2.4272903399433352e-48
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD274,Programmed cell death 1 ligand 1,46337,124,3.79 [2.89-4.96],3.7140224623955613e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD276,CD276 antigen,46670,123,11.16 [7.85-15.86],3.317356283533556e-41
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD28,T-cell-specific surface glycoprotein CD28,45615,120,2.80 [2.29-3.41],5.121848574648335e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD300A,CMRF35-like molecule 8,39729,105,6.46 [4.01-10.43],2.009274390458337e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD300C,CMRF35-like molecule 6,47117,128,4.21 [3.05-5.81],2.184481533643953e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD300E,CMRF35-like molecule 2,46946,127,4.13 [3.12-5.47],3.6589309164074896e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD300LF,CMRF35-like molecule 1,47097,128,2.01 [1.50-2.70],3.657173139719557e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD300LG,CMRF35-like molecule 9,46698,127,1.54 [1.01-2.34],0.0445709812418926
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD302,CD302 antigen,46483,124,5.77 [4.50-7.39],1.5835880408540182e-43
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD34,Hematopoietic progenitor cell antigen CD34,46967,127,0.35 [0.18-0.67],0.001412074377756
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD36,Platelet glycoprotein 4,39446,103,1.96 [1.35-2.83],0.0003597354732446
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,46483,124,5.06 [3.39-7.55],2.284157089346856e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD40,Tumor necrosis factor receptor superfamily member 5,46668,124,2.25 [1.73-2.93],1.252182353203624e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD46,Membrane cofactor protein,46428,125,4.20 [2.97-5.95],5.51392774432506e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD48,CD48 antigen,46823,124,6.28 [4.38-8.99],1.155326184639097e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD5,T-cell surface glycoprotein CD5,47028,128,2.35 [1.97-2.81],1.872850211106139e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD55,Complement decay-accelerating factor,45075,119,3.71 [2.70-5.10],7.485935424649421e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD59,CD59 glycoprotein,45016,122,6.12 [4.43-8.47],7.941478825815839e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD5L,CD5 antigen-like,40456,105,1.50 [1.02-2.21],0.0381799726430733
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD63,CD63 antigen,46258,124,1.76 [1.28-2.44],0.000602665764278
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD7,T-cell antigen CD7,39374,102,2.67 [2.02-3.52],3.814204293516689e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD70,CD70 antigen,46626,123,2.42 [1.82-3.21],9.80449182302916e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD72,B-cell differentiation antigen CD72,39729,105,2.48 [1.84-3.35],2.343434819520022e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD74,HLA class II histocompatibility antigen gamma chain,47117,128,7.04 [5.08-9.74],6.122640835514551e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD79B,B-cell antigen receptor complex-associated protein beta chain,47210,127,3.04 [2.50-3.70],4.2771936427676965e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD80,T-lymphocyte activation antigen CD80,40628,107,4.56 [3.36-6.19],1.7223952865181611e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD82,CD82 antigen,39882,107,1.43 [1.02-2.00],0.0402689509042289
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD83,CD83 antigen,46626,123,4.41 [3.34-5.83],2.2213955326867937e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD8A,T-cell surface glycoprotein CD8 alpha chain,47117,128,1.99 [1.55-2.55],5.1271742542341486e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD93,Complement component C1q receptor,44916,119,2.86 [1.78-4.59],1.479826723004158e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD99,CD99 antigen,46698,127,6.68 [3.81-11.73],3.5539569656007544e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD99L2,CD99 antigen-like protein 2,46698,127,3.44 [1.89-6.28],5.622879028666308e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDC27,Cell division cycle protein 27 homolog,45615,120,1.31 [1.03-1.67],0.0250561640352253
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDC42BPB,Serine/threonine-protein kinase MRCK beta,40451,106,1.22 [1.03-1.45],0.0212186754502817
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDCP1,CUB domain-containing protein 1,46337,124,2.69 [2.17-3.32],6.209739883992403e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDH1,Cadherin-1,45157,120,2.62 [2.18-3.13],1.826558122987095e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDH15,Cadherin-15,47041,127,1.66 [1.39-1.98],1.536599841153002e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDH17,Cadherin-17,46694,125,2.12 [1.75-2.57],3.364658970372695e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDH2,Cadherin-2,46694,125,5.60 [3.66-8.58],2.299060907437496e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDH3,Cadherin-3,47117,128,2.79 [1.95-3.98],1.7040231680119315e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDH5,Cadherin-5,47267,128,1.75 [1.06-2.88],0.0274231449490416
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDH6,Cadherin-6,46694,125,3.01 [2.22-4.07],1.375600497186241e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDHR2,Cadherin-related family member 2,46483,124,1.36 [1.05-1.75],0.0180626368817127
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDKN1A,Cyclin-dependent kinase inhibitor 1,46483,124,1.27 [1.10-1.48],0.0013103227643717
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDNF,Cerebral dopamine neurotrophic factor,46483,124,1.90 [1.40-2.59],4.23896943067798e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,46745,123,1.95 [1.06-3.57],0.0318561376649555
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDSN,Corneodesmosin,47070,127,1.86 [1.32-2.62],0.0003566107758521
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,46780,129,2.97 [1.52-5.81],0.0015039958563112
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,40451,106,2.23 [1.56-3.20],1.325624956233588e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,46626,123,1.30 [1.09-1.54],0.0031850889440075
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,45017,118,1.73 [1.39-2.16],1.2375488824504029e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,40614,105,1.89 [1.50-2.38],4.852684171319902e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,45838,124,1.83 [1.40-2.40],1.296336222668096e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,39729,105,2.01 [1.09-3.69],0.0247972073555977
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEMIP2,Cell surface hyaluronidase,39446,103,1.72 [1.27-2.32],0.0004040878642744
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CENPJ,Centromere protein J,39882,107,1.26 [1.01-1.56],0.0366307076074448
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CES1,Liver carboxylesterase 1,46806,124,1.27 [1.08-1.50],0.0038904419814154
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CES2,Cocaine esterase,46483,124,1.69 [1.33-2.15],2.0846287607584467e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CFB,Complement factor B,39942,105,2.86 [1.57-5.20],0.0005853287203816
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CFC1,Cryptic protein,45615,120,2.21 [1.75-2.78],2.0298527823631093e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CFD,Complement factor D,40679,105,4.08 [2.57-6.48],2.610993786729857e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CFH,Complement factor H,38313,101,3.13 [1.35-7.28],0.0079238341430323
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CFHR4,Complement factor H-related protein 4,40600,105,0.72 [0.57-0.92],0.0078016504640264
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CFI,Complement factor I,40679,105,5.39 [2.09-13.92],0.0005056646334277
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CGA,Glycoprotein hormones alpha chain,46698,127,1.88 [1.53-2.30],1.212229219712304e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CGREF1,Cell growth regulator with EF hand domain protein 1,46694,125,3.94 [2.83-5.49],4.519577291194125e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHAD,Chondroadherin,39729,105,0.51 [0.42-0.64],8.194090045233885e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",40529,106,3.08 [2.58-3.67],6.219769466294398e-36
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHCHD6,MICOS complex subunit MIC25,40433,105,2.87 [2.15-3.82],5.289789895329107e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHGA,Chromogranin-A,40614,105,1.79 [1.57-2.04],1.3914203628289257e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHGB,Secretogranin-1,46967,127,2.56 [1.85-3.53],1.189161067397408e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHI3L1,Chitinase-3-like protein 1,45685,121,1.98 [1.71-2.29],1.3702705529416942e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHRDL1,Chordin-like protein 1,46823,124,5.15 [3.34-7.93],1.0229280300192205e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CILP,Cartilage intermediate layer protein 1,40614,105,3.52 [2.80-4.43],3.243642627621925e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CKAP4,Cytoskeleton-associated protein 4,46978,127,4.89 [3.90-6.14],8.404840143141878e-43
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CKB,Creatine kinase B-type,40614,105,1.58 [1.16-2.15],0.0039807890165648
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",46517,124,1.60 [1.25-2.05],0.0001920573329285
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC10A,C-type lectin domain family 10 member A,46337,124,2.70 [1.74-4.20],1.0528132785279786e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC12A,C-type lectin domain family 12 member A,39446,103,3.03 [1.75-5.24],7.793585381613919e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC14A,C-type lectin domain family 14 member A,46698,127,4.09 [2.75-6.09],3.718933465516456e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC1A,C-type lectin domain family 1 member A,45838,124,3.46 [2.35-5.10],3.4399166772525576e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC3B,Tetranectin,39735,105,0.33 [0.20-0.55],2.013302723012984e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC4A,C-type lectin domain family 4 member A,46626,123,0.36 [0.25-0.53],1.4494055818158521e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC4C,C-type lectin domain family 4 member C,46626,123,0.68 [0.49-0.94],0.0207295735213864
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC4D,C-type lectin domain family 4 member D,46626,123,2.01 [1.60-2.52],1.2758842113839975e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC5A,C-type lectin domain family 5 member A,46538,125,3.82 [2.48-5.87],1.0741673069442747e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC6A,C-type lectin domain family 6 member A,45615,120,2.67 [2.02-3.52],5.514065306843622e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC7A,C-type lectin domain family 7 member A,47210,127,2.24 [1.61-3.13],2.034649322837968e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLGN,Calmegin,39492,104,1.92 [1.51-2.45],1.346839793283906e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLMP,CXADR-like membrane protein,47097,128,8.19 [5.10-13.16],3.260865112389615e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLSTN2,Calsyntenin-2,47210,127,2.99 [2.34-3.81],8.637475722460147e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLSTN3,Calsyntenin-3,40529,106,2.83 [1.78-4.50],1.039135501336566e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLUL1,Clusterin-like protein 1,46620,125,0.42 [0.30-0.60],2.172467625411096e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CNST,Consortin,46694,125,1.15 [1.00-1.33],0.0465036522580743
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CNTN2,Contactin-2,47097,128,2.14 [1.53-2.99],8.700106391913264e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CNTN3,Contactin-3,46698,127,2.56 [1.47-4.45],0.0008455985172917
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CNTN4,Contactin-4,46698,127,3.90 [2.09-7.29],1.949069348308644e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CNTN5,Contactin-5,46822,126,0.37 [0.24-0.57],8.184822142269484e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CNTNAP2,Contactin-associated protein-like 2,46626,123,2.30 [1.71-3.08],2.8749796806807343e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COCH,Cochlin,40628,107,1.49 [1.02-2.17],0.038974546211693
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL18A1,Collagen alpha-1(XVIII) chain,46891,127,17.94 [10.52-30.58],2.770814705698849e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL1A1,Collagen alpha-1(I) chain,47267,128,0.44 [0.22-0.89],0.0212659421263361
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL3A1,Collagen alpha-1(III) chain,40614,105,3.96 [2.12-7.39],1.6280088979229814e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL4A1,Collagen alpha-1(IV) chain,46694,125,4.37 [3.15-6.06],9.229225122317784e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL5A1,Collagen alpha-1(V) chain,39729,105,2.90 [2.11-3.97],4.437037522493543e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL6A3,Collagen alpha-3(VI) chain,47267,128,5.12 [3.94-6.66],2.396938739713512e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COLEC12,Collectin-12,46670,123,9.66 [6.63-14.08],4.2205674742699365e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CORO6,Coronin-6,39312,102,1.69 [1.20-2.37],0.0023937903814628
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",46483,124,1.29 [1.05-1.58],0.0149769520680398
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COX6B1,Cytochrome c oxidase subunit 6B1,40628,107,2.25 [1.43-3.56],0.0004765333137337
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPA2,Carboxypeptidase A2,46961,127,2.06 [1.68-2.54],9.147716231610136e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPE,Carboxypeptidase E,46739,126,0.60 [0.42-0.84],0.0034727172894353
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPM,Carboxypeptidase M,46893,127,5.75 [4.03-8.21],6.663665865452723e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPPED1,Serine/threonine-protein phosphatase CPPED1,47117,128,0.77 [0.60-0.98],0.0368272052968709
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPVL,Probable serine carboxypeptidase CPVL,47019,128,2.01 [1.36-2.98],0.0004971048517753
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPXM2,Inactive carboxypeptidase-like protein X2,40628,107,4.57 [3.29-6.35],1.2637177829126113e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CR1,Complement receptor type 1,40490,105,2.90 [2.14-3.94],8.344435673583283e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CR2,Complement receptor type 2,46888,125,2.42 [1.78-3.29],1.7961560932702082e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,45615,120,1.20 [1.01-1.44],0.0438558487405838
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRELD1,Protein disulfide isomerase CRELD1,39729,105,5.59 [3.53-8.87],2.539926365692515e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRELD2,Protein disulfide isomerase CRELD2,46823,124,2.16 [1.65-2.82],1.8392208357661522e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRH,Corticoliberin,45538,119,0.63 [0.51-0.76],4.519157442468347e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRHBP,Corticotropin-releasing factor-binding protein,46670,123,8.44 [4.90-14.55],1.5725106753999186e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRIM1,Cysteine-rich motor neuron 1 protein,46900,124,11.22 [5.98-21.05],5.0201726812663125e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRIP2,Cysteine-rich protein 2,46337,124,2.17 [1.78-2.64],1.4289367605734137e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRISP2,Cysteine-rich secretory protein 2,47097,128,0.69 [0.54-0.88],0.0032936470180276
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRLF1,Cytokine receptor-like factor 1,46900,124,3.67 [2.00-6.73],2.7106867814382662e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRTAC1,Cartilage acidic protein 1,47267,128,0.50 [0.31-0.80],0.0045251701791744
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRTAM,Cytotoxic and regulatory T-cell molecule,46337,124,2.06 [1.52-2.80],3.779807867535272e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRYBB1,Beta-crystallin B1,40628,107,1.42 [1.09-1.85],0.0104008383460563
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSF1,Macrophage colony-stimulating factor 1,46900,124,11.01 [6.95-17.43],1.6151784013520003e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSF1R,Macrophage colony-stimulating factor 1 receptor,40646,105,2.87 [2.05-4.02],8.720304377559162e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,46337,124,1.58 [1.28-1.96],2.7932077600891268e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSF3R,Granulocyte colony-stimulating factor receptor,39446,103,1.80 [1.10-2.95],0.0190891542621223
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSPG4,Chondroitin sulfate proteoglycan 4,40614,105,2.26 [1.29-3.95],0.0042952135895259
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSRP3,Cysteine and glycine-rich protein 3,39283,102,1.43 [1.26-1.63],7.038293776703668e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CST3,Cystatin-C,46819,125,6.73 [4.79-9.45],3.042775054633414e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CST5,Cystatin-D,45806,123,1.49 [1.12-1.99],0.0056567960480738
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CST6,Cystatin-M,45471,123,1.47 [1.07-2.01],0.0162379580093176
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CST7,Cystatin-F,46745,124,1.34 [1.19-1.50],1.0188598904355525e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSTB,Cystatin-B,46044,121,2.34 [1.73-3.17],4.09037859706804e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTBS,Di-N-acetylchitobiase,40064,102,3.43 [1.68-6.98],0.0006823635711505
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTHRC1,Collagen triple helix repeat-containing protein 1,40614,105,3.94 [2.49-6.23],4.250716157109641e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTRB1,Chymotrypsinogen B,46698,127,0.75 [0.56-0.99],0.0410308508584267
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTRC,Chymotrypsin-C,46668,123,0.61 [0.48-0.77],4.692814372431126e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTRL,Chymotrypsin-like protease CTRL-1,40529,106,0.58 [0.45-0.75],2.4501129237422025e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSB,Cathepsin B,46745,127,1.60 [1.21-2.11],0.0009048400167096
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSD,Cathepsin D,43631,114,2.83 [2.28-3.51],4.15748238369954e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSE,Cathepsin E,39729,105,2.09 [1.48-2.95],2.6513607820582364e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSH,Pro-cathepsin H,45677,124,1.32 [1.07-1.63],0.0092589393600231
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSL,Cathepsin L1,46694,125,7.87 [4.60-13.46],5.2260896453705485e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSO,Cathepsin O,47210,127,4.34 [3.06-6.16],1.741932459737473e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSS,Cathepsin S,36692,100,13.08 [6.78-25.24],1.7593233476915663e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSZ,Cathepsin Z,46737,125,6.36 [4.11-9.83],1.0067909841921902e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CUZD1,CUB and zona pellucida-like domain-containing protein 1,39492,104,1.54 [1.10-2.16],0.0120492342804405
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CX3CL1,Fractalkine,46337,124,2.57 [1.72-3.83],3.508334351756273e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXADR,Coxsackievirus and adenovirus receptor,46626,123,2.12 [1.65-2.74],5.449781783784434e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL1,Growth-regulated alpha protein,46593,124,1.25 [1.08-1.45],0.0026488365227836
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL11,C-X-C motif chemokine 11,47117,128,1.22 [1.03-1.45],0.0219780367815877
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL13,C-X-C motif chemokine 13,47117,128,1.43 [1.26-1.62],1.12647912013591e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL14,C-X-C motif chemokine 14,45833,124,1.33 [1.14-1.56],0.0003581406261063
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL16,C-X-C motif chemokine 16,47187,128,5.52 [3.11-9.79],5.241807859855444e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL17,C-X-C motif chemokine 17,47210,127,1.81 [1.37-2.39],2.864072856153764e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL6,C-X-C motif chemokine 6,47210,127,1.36 [1.11-1.66],0.0028474645215297
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL8,Interleukin-8,46351,127,1.42 [1.22-1.65],5.8742196440592975e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL9,C-X-C motif chemokine 9,46900,124,1.72 [1.42-2.08],2.9047197352962734e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DAG1,Dystroglycan,46900,124,2.24 [1.62-3.08],8.225219372546324e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DBI,Acyl-CoA-binding protein,46482,126,1.33 [1.08-1.62],0.0065399247157835
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DBN1,Drebrin,39446,103,1.44 [1.02-2.04],0.0372729726180485
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",46850,129,4.91 [3.77-6.38],1.6195553156956123e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DCN,Decorin,45838,124,7.10 [4.19-12.01],2.902738371362885e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",46483,124,2.49 [1.89-3.28],6.968257776629859e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DDI2,Protein DDI1 homolog 2,39729,105,0.76 [0.59-0.97],0.0272143214743535
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DDR1,Epithelial discoidin domain-containing receptor 1,47117,128,7.07 [4.37-11.42],1.4436410723199405e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",46626,123,1.21 [1.03-1.43],0.0202387736129564
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DEFA1_DEFA1B,Neutrophil defensin 1,45757,124,1.88 [1.56-2.28],4.5846437157642285e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DEFB103A_DEFB103B,Beta-defensin 103,39143,103,1.80 [1.46-2.23],6.370993903058932e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DEFB104A_DEFB104B,Beta-defensin 104,39312,102,0.65 [0.43-0.98],0.0416267079704163
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DEFB4A_DEFB4B,Beta-defensin 4A,46025,124,1.26 [1.13-1.41],2.467111424714752e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DHPS,Deoxyhypusine synthase,40433,105,1.41 [1.04-1.90],0.0255924829222769
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,40529,106,1.45 [1.08-1.96],0.0148438986831454
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DKK1,Dickkopf-related protein 1,47117,128,1.30 [1.00-1.68],0.04931260035814
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DKK3,Dickkopf-related protein 3,47267,128,3.08 [1.85-5.14],1.5500901011962692e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DKK4,Dickkopf-related protein 4,46259,124,3.03 [2.48-3.69],1.1599970697212506e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DKKL1,Dickkopf-like protein 1,46483,124,1.24 [1.01-1.53],0.0404037822572515
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DLL1,Delta-like protein 1,46850,129,9.16 [6.62-12.69],1.1863497610489595e-40
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DMD,Dystrophin,39538,103,1.81 [1.46-2.25],5.269600050693437e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DMP1,Dentin matrix acidic phosphoprotein 1,39538,103,0.38 [0.32-0.46],6.234596605412658e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNAJB14,DnaJ homolog subfamily B member 14,40451,106,1.42 [1.09-1.85],0.0092209555260537
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNER,Delta and Notch-like epidermal growth factor-related receptor,46594,123,0.53 [0.37-0.75],0.0003492226273078
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNM3,Dynamin-3,40550,105,1.80 [1.45-2.25],1.504469415186715e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNMBP,Dynamin-binding protein,46337,124,1.46 [1.15-1.85],0.0017858825644827
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,46824,124,0.66 [0.48-0.89],0.0078133327373227
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DPP10,Inactive dipeptidyl peptidase 10,46626,123,2.15 [1.53-3.03],1.1313840610548432e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DPP4,Dipeptidyl peptidase 4,45823,125,0.41 [0.24-0.70],0.0010174932226048
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DPP6,Dipeptidyl aminopeptidase-like protein 6,46483,124,4.17 [2.74-6.33],2.1999416480375448e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DPP7,Dipeptidyl peptidase 2,46316,125,1.45 [1.13-1.84],0.0029220140709789
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DPT,Dermatopontin,47267,128,9.11 [4.60-18.03],2.302075941057673e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DPY30,Protein dpy-30 homolog,46950,128,1.98 [1.66-2.37],5.3084968916000754e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DRAXIN,Draxin,46337,124,2.38 [1.76-3.20],1.255302568253083e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DSC2,Desmocollin-2,46177,126,5.16 [4.03-6.61],1.9011427311598511e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DSCAM,Down syndrome cell adhesion molecule,40550,105,3.69 [2.27-5.99],1.2569681915031634e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DSG2,Desmoglein-2,46698,127,2.32 [1.37-3.92],0.0016318191685509
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DSG4,Desmoglein-4,46338,123,0.46 [0.34-0.62],5.611265690941601e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DTNB,Dystrobrevin beta,40358,105,3.37 [2.64-4.29],8.657627561977511e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DTX2,Probable E3 ubiquitin-protein ligase DTX2,39492,104,0.66 [0.45-0.97],0.0359876959844946
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DTX3,Probable E3 ubiquitin-protein ligase DTX3,46483,124,2.58 [1.66-3.99],2.3353922973983464e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",40451,106,1.28 [1.08-1.51],0.0037707371310222
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DYNLT1,Dynein light chain Tctex-type 1,39492,104,1.34 [1.09-1.65],0.0047438816197906
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EBI3_IL27,Interleukin-27,47029,128,4.81 [3.20-7.21],3.383264456026217e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",40628,107,1.41 [1.14-1.75],0.0014823648677718
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ECHS1,"Enoyl-CoA hydratase, mitochondrial",39538,103,1.40 [1.17-1.69],0.0002928024158804
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EDA2R,Tumor necrosis factor receptor superfamily member 27,47097,128,5.38 [4.36-6.64],3.353465051538588e-55
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,45838,124,2.55 [1.77-3.68],5.40646538256138e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EDN1,Endothelin-1,39538,103,5.84 [3.66-9.30],1.1133002878520469e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EEF1D,Elongation factor 1-delta,40628,107,1.29 [1.06-1.57],0.0095995801660145
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EFCAB14,EF-hand calcium-binding domain-containing protein 14,40451,106,2.01 [1.57-2.57],3.495096030187229e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,46809,125,7.70 [5.25-11.30],1.6151961705734324e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EFHD1,EF-hand domain-containing protein D1,40550,105,1.84 [1.28-2.66],0.0010781166467366
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EFNA1,Ephrin-A1,46618,126,6.47 [4.83-8.67],4.816016223349088e-36
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EFNB2,Ephrin-B2,39492,104,1.33 [1.04-1.70],0.0234723820209249
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EGFL7,Epidermal growth factor-like protein 7,45615,120,2.04 [1.53-2.71],1.1319027505273188e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EGFLAM,Pikachurin,40451,106,2.11 [1.33-3.35],0.0015156374979189
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EGLN1,Egl nine homolog 1,46626,123,1.25 [1.00-1.55],0.0461946538388833
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EHBP1,EH domain-binding protein 1,40628,107,1.28 [1.01-1.62],0.039344575070377
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,47210,127,1.19 [1.01-1.41],0.0344934970227622
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ELN,Elastin,40628,107,3.52 [2.14-5.81],8.036172000956755e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ELOB,Elongin-B,39283,102,1.45 [1.00-2.11],0.0499792926944321
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENAH,Protein enabled homolog,45833,124,1.91 [1.46-2.48],1.682283958211763e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENDOU,Poly(U)-specific endoribonuclease,37501,103,1.58 [1.16-2.17],0.0042439155805406
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENG,Endoglin,47267,128,4.56 [2.17-9.59],6.247989444037537e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENO3,Beta-enolase,39538,103,0.70 [0.50-0.98],0.0376480942485129
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,39283,102,1.80 [1.01-3.18],0.0446257528693996
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,47267,128,3.62 [2.20-5.96],3.825850274913776e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,45272,120,1.37 [1.14-1.65],0.0009864295740406
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,45838,124,0.31 [0.16-0.60],0.0006043780363328
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,45838,124,2.27 [1.16-4.43],0.0164821947694199
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EP300,Histone acetyltransferase p300,39446,103,1.96 [1.43-2.69],3.124879852829229e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPHA1,Ephrin type-A receptor 1,46824,124,3.69 [2.24-6.10],3.231605676157862e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPHA2,Ephrin type-A receptor 2,45016,122,4.08 [3.41-4.87],4.04223627185639e-54
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPHA4,Ephrin type-A receptor 4,39729,105,2.65 [1.40-5.00],0.0026816522114562
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPHB4,Ephrin type-B receptor 4,47267,128,8.27 [5.66-12.08],9.55664045346816e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPHB6,Ephrin type-B receptor 6,46261,123,4.09 [2.77-6.05],1.639854020347238e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPO,Erythropoietin,46626,123,1.41 [1.24-1.61],3.005082337152044e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,47018,128,3.57 [2.63-4.84],3.279609508516541e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ERBB2,Receptor tyrosine-protein kinase erbB-2,46850,129,1.89 [1.02-3.48],0.0423611425106476
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ERBB3,Receptor tyrosine-protein kinase erbB-3,46514,123,3.85 [1.87-7.94],0.000260191352868
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ERBB4,Receptor tyrosine-protein kinase erbB-4,46850,129,3.63 [1.95-6.74],4.534805020860058e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ERMAP,Erythroid membrane-associated protein,39446,103,3.10 [2.13-4.50],2.915355300318571e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ESAM,Endothelial cell-selective adhesion molecule,47267,128,4.41 [3.02-6.42],1.2404178264276988e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ESYT2,Extended synaptotagmin-2,40529,106,1.41 [1.14-1.74],0.0015998031671432
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EVI5,Ecotropic viral integration site 5 protein homolog,39446,103,1.31 [1.07-1.61],0.0097586313171827
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,F11,Coagulation factor XI,40083,105,1.60 [1.09-2.36],0.0167632113292204
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,F11R,Junctional adhesion molecule A,46698,127,1.70 [1.31-2.19],4.9523820472249535e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,F2R,Proteinase-activated receptor 1,46823,124,2.01 [1.53-2.63],5.357236478239403e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,F3,Tissue factor,46811,128,2.44 [1.41-4.23],0.0015103927238041
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,F9,Coagulation factor IX,46810,125,6.74 [3.06-14.83],2.160827923465456e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FABP1,"Fatty acid-binding protein, liver",46670,123,1.91 [1.68-2.19],8.28393426644526e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FABP2,"Fatty acid-binding protein, intestinal",46694,125,1.31 [1.10-1.57],0.0029560484786612
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FABP3,"Fatty acid-binding protein, heart",40628,107,0.47 [0.28-0.80],0.004667076332186
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FABP4,"Fatty acid-binding protein, adipocyte",47267,128,3.43 [2.81-4.18],5.5696437797208245e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FABP5,Fatty acid-binding protein 5,46961,128,1.46 [1.17-1.81],0.0006958108608406
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FAM20A,Pseudokinase FAM20A,40628,107,3.16 [2.13-4.68],9.882275801289668e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FAM3B,Protein FAM3B,46483,124,10.31 [6.42-16.54],4.039749814517349e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FAM3C,Protein FAM3C,46621,125,13.03 [9.31-18.24],1.1151368828277048e-50
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FAM3D,Protein FAM3D,40451,106,2.80 [2.23-3.51],4.897826220948484e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FAS,Tumor necrosis factor receptor superfamily member 6,47110,128,1.99 [1.60-2.48],9.50953347696179e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FBLN2,Fibulin-2,40614,105,4.77 [3.08-7.38],2.351024510606341e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,40628,107,1.92 [1.52-2.43],5.1971014210549144e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCAR,Immunoglobulin alpha Fc receptor,46626,123,2.30 [1.66-3.18],4.7252472944070134e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCER2,Low affinity immunoglobulin epsilon Fc receptor,46698,127,1.58 [1.28-1.95],2.1564037187582107e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,46498,125,2.11 [1.51-2.94],1.0603914949821903e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCN1,Ficolin-1,40567,105,3.26 [2.21-4.82],2.576245219663293e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCN2,Ficolin-2,46506,124,0.60 [0.44-0.82],0.0014501644111173
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCRL1,Fc receptor-like protein 1,46694,125,1.45 [1.06-1.97],0.0185950579195995
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCRL2,Fc receptor-like protein 2,46985,125,1.80 [1.42-2.27],9.02294880538632e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCRL5,Fc receptor-like protein 5,46698,127,1.36 [1.06-1.76],0.017493480325065
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCRL6,Fc receptor-like protein 6,46626,123,1.61 [1.28-2.02],3.989901634857977e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCRLB,Fc receptor-like B,45615,120,1.53 [1.32-1.76],6.1552446999983165e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FDX1,"Adrenodoxin, mitochondrial",39283,102,1.54 [1.28-1.87],8.440197061145587e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FDX2,"Ferredoxin-2, mitochondrial",39283,102,1.36 [1.02-1.81],0.0347789309839048
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FETUB,Fetuin-B,46810,125,1.73 [1.01-2.95],0.0447242671498109
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGA,Fibrinogen alpha chain,39727,105,2.48 [1.38-4.44],0.0022995847429892
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGF2,Fibroblast growth factor 2,46626,123,1.36 [1.10-1.68],0.0044898935474757
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGF21,Fibroblast growth factor 21,47029,128,1.53 [1.37-1.71],2.0502937522158635e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGF23,Fibroblast growth factor 23,47027,128,1.83 [1.59-2.11],1.2630344419693324e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGF5,Fibroblast growth factor 5,45833,124,3.60 [2.82-4.59],4.865669484999655e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGFBP1,Fibroblast growth factor-binding protein 1,46850,129,0.32 [0.24-0.41],2.3336349173797866e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGFBP2,Fibroblast growth factor-binding protein 2,40614,105,0.38 [0.26-0.55],2.152147976100701e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGFBP3,Fibroblast growth factor-binding protein 3,40529,106,0.49 [0.30-0.81],0.0058935703260992
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGFR2,Fibroblast growth factor receptor 2,46850,129,11.48 [7.53-17.49],6.409192563999904e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGL1,Fibrinogen-like protein 1,40646,105,2.37 [1.86-3.02],2.2705365979490087e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,46337,124,1.57 [1.08-2.29],0.0176997574110853
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,46337,124,4.63 [3.06-7.01],4.724316508374363e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FLT1,Vascular endothelial growth factor receptor 1,46403,124,2.05 [1.35-3.12],0.0007600642894931
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FLT3LG,Fms-related tyrosine kinase 3 ligand,47210,127,2.07 [1.33-3.23],0.001338113946452
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FOLR1,Folate receptor alpha,46635,129,3.48 [2.60-4.65],5.1507313180801507e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FOLR2,Folate receptor beta,47117,128,2.24 [1.35-3.73],0.0018557598402963
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FOLR3,Folate receptor gamma,46702,129,1.09 [1.02-1.17],0.0111425607682165
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FSHB,Follitropin subunit beta,39538,103,1.51 [1.07-2.11],0.0175937876154207
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FSTL1,Follistatin-related protein 1,39538,103,6.09 [3.79-9.78],8.464311526324213e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FSTL3,Follistatin-related protein 3,46592,123,8.04 [5.99-10.78],7.272451841167429e-44
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FTCD,Formimidoyltransferase-cyclodeaminase,40454,106,1.34 [1.10-1.62],0.0031513483501054
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FUOM,Fucose mutarotase,39729,105,1.33 [1.00-1.75],0.0464854182488724
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FURIN,Furin,46850,129,1.64 [1.02-2.64],0.0400732367253047
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,47117,128,1.91 [1.38-2.65],0.0001009895317492
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FZD8,Frizzled-8,39312,102,1.38 [1.01-1.88],0.0414622416965149
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GAD2,Glutamate decarboxylase 2,39446,103,1.34 [1.04-1.74],0.02369105729054
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,39538,103,1.37 [1.01-1.85],0.0438103656927729
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,46483,124,4.96 [3.10-7.96],2.836578799173816e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,47097,128,0.48 [0.27-0.85],0.0122088989426649
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,45833,124,1.96 [1.46-2.63],8.482814153444895e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GALNT7,N-acetylgalactosaminyltransferase 7,46483,124,4.22 [1.98-9.01],0.0001922724345434
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GAS6,Growth arrest-specific protein 6,46958,126,3.08 [1.67-5.68],0.00032593689655
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GASK1A,Golgi-associated kinase 1A,39283,102,0.48 [0.31-0.74],0.0010033397536353
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GAST,Gastrin,40529,106,1.44 [1.30-1.59],1.2693430372206457e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GCG,Pro-glucagon,45615,120,1.94 [1.70-2.21],4.6954566036380093e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,38762,102,1.69 [1.27-2.23],0.0002610427901252
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",46483,124,4.17 [2.77-6.28],7.660490352552645e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GDF15,Growth/differentiation factor 15,47267,128,3.59 [3.19-4.04],5.714762320519955e-98
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GDF2,Growth/differentiation factor 2,46694,125,1.75 [1.14-2.68],0.0105228600591734
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GDNF,Glial cell line-derived neurotrophic factor,45638,124,2.47 [1.81-3.36],8.473196902092569e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GFER,FAD-linked sulfhydryl oxidase ALR,45615,120,1.56 [1.23-1.96],0.0002010679566452
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,45615,120,0.82 [0.69-0.99],0.0362370325989625
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GFRA1,GDNF family receptor alpha-1,47029,128,12.25 [8.62-17.39],1.7755157879345446e-44
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GFRA2,GDNF family receptor alpha-2,46483,124,3.10 [1.66-5.78],0.0003754700053284
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GFRA3,GDNF family receptor alpha-3,46191,124,2.19 [1.28-3.74],0.0041305521979465
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GFRAL,GDNF family receptor alpha-like,39319,102,0.72 [0.53-1.00],0.0469139813449943
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GGT1,Glutathione hydrolase 1 proenzyme,46618,126,1.92 [1.50-2.45],1.897829930447778e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GH1,Somatotropin,46621,125,1.12 [1.02-1.22],0.0139327537569347
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GIGYF2,GRB10-interacting GYF protein 2,40550,105,1.47 [1.17-1.85],0.0008530314232377
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GIMAP7,GTPase IMAP family member 7,39729,105,0.33 [0.17-0.66],0.0015750271072533
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GIP,Gastric inhibitory polypeptide,39538,103,1.99 [1.51-2.63],9.131111691468412e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GIPC2,PDZ domain-containing protein GIPC2,40529,106,4.92 [3.46-7.00],8.29814748907939e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GJA8,Gap junction alpha-8 protein,39172,104,0.68 [0.47-0.99],0.0453453616209566
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GKN1,Gastrokine-1,44764,122,1.95 [1.21-3.16],0.0060988747046866
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GLA,Alpha-galactosidase A,39655,104,2.56 [1.69-3.89],9.958383364151691e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GLB1,Beta-galactosidase,46337,124,1.47 [1.02-2.11],0.0410230973199805
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GLI2,Zinc finger protein GLI2,39446,103,1.69 [1.09-2.62],0.0186152529397169
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GM2A,Ganglioside GM2 activator,39621,104,1.87 [1.56-2.24],1.1170760785765464e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GMPR,GMP reductase 1,47210,127,0.63 [0.47-0.84],0.001720498412477
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GNAS,Neuroendocrine secretory protein 55,40550,105,1.26 [1.06-1.51],0.010706865666658
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GNPDA2,Glucosamine-6-phosphate isomerase 2,39729,105,0.47 [0.28-0.79],0.0043744933714997
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GOLGA3,Golgin subfamily A member 3,40550,105,1.42 [1.14-1.77],0.0016452061130408
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GOLM2,Protein GOLM2,47117,128,6.05 [4.02-9.10],5.78973535016697e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPA33,Cell surface A33 antigen,46483,124,0.76 [0.67-0.86],7.766173908764032e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPC1,Glypican-1,47097,128,2.34 [1.39-3.92],0.0013384678800592
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPC5,Glypican-5,46337,124,0.57 [0.43-0.75],7.095198573733095e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPD1,Glycerol-3-phosphate dehydrogenase,40433,105,1.87 [1.41-2.48],1.5702510852487468e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPKOW,G-patch domain and KOW motifs-containing protein,45638,124,1.44 [1.01-2.04],0.0436120395346481
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPNMB,Transmembrane glycoprotein NMB,45423,120,7.10 [4.28-11.79],3.550250844072318e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPR15L,Protein GPR15L,40451,106,1.82 [1.39-2.37],1.0386237480346428e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPR37,Prosaposin receptor GPR37,45838,124,3.47 [2.84-4.25],9.423128313888756e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPRC5C,G-protein coupled receptor family C group 5 member C,40433,105,1.75 [1.45-2.11],6.762665049404709e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GRN,Progranulin,46467,126,5.76 [3.89-8.53],2.788382635599556e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GRPEL1,"GrpE protein homolog 1, mitochondrial",46483,124,2.22 [1.87-2.64],2.437204570708852e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GRSF1,G-rich sequence factor 1,38962,104,1.27 [1.03-1.56],0.0281988841298516
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GSN,Gelsolin,40489,104,6.37 [3.84-10.58],8.09802913140458e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GSTP1,Glutathione S-transferase P,45347,124,0.71 [0.55-0.93],0.0118550979302244
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GUCA2A,Guanylin,46464,127,3.99 [2.97-5.37],5.371784801306187e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GUSB,Beta-glucuronidase,46891,128,1.36 [1.07-1.73],0.0131074957283103
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GZMA,Granzyme A,47210,127,2.09 [1.41-3.08],0.0002181407066631
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",46960,128,0.67 [0.53-0.84],0.0006799834028666
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HAO1,Hydroxyacid oxidase 1,47097,128,1.33 [1.18-1.50],2.86712865435243e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HAVCR1,Hepatitis A virus cellular receptor 1,47028,128,3.10 [2.67-3.59],1.8492046369270072e-51
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HAVCR2,Hepatitis A virus cellular receptor 2,46698,127,4.69 [3.54-6.23],8.283466973532716e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HBQ1,Hemoglobin subunit theta-1,47097,128,0.55 [0.42-0.73],3.625310709287563e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HBZ,Hemoglobin subunit zeta,40628,107,0.77 [0.64-0.93],0.0072704643611222
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HEG1,Protein HEG homolog 1,39729,105,4.69 [2.52-8.71],1.0210512640758506e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HEPH,Hephaestin,40628,107,8.87 [4.40-17.88],1.0333608272139887e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HEXIM1,Protein HEXIM1,46626,123,1.24 [1.02-1.51],0.0287266106897042
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HGF,Hepatocyte growth factor,47210,127,3.71 [2.67-5.16],6.353486026355903e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HHEX,Hematopoietically-expressed homeobox protein HHEX,40529,106,1.48 [1.17-1.88],0.0010331546489665
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HIP1R,Huntingtin-interacting protein 1-related protein,40450,105,2.10 [1.74-2.52],3.032722759640179e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HJV,Hemojuvelin,40550,105,1.74 [1.37-2.21],4.494629434392948e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HLA-A,"HLA class I histocompatibility antigen, A alpha chain",40550,105,3.00 [1.69-5.33],0.000184559534736
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",46482,122,1.82 [1.21-2.74],0.00423063302656
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HLA-E,"HLA class I histocompatibility antigen, alpha chain E",46626,123,5.39 [3.83-7.59],5.689537772302103e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HMBS,Porphobilinogen deaminase,47097,128,0.49 [0.34-0.70],0.000101776045561
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HMCN2,Hemicentin-2,39657,105,1.79 [1.29-2.50],0.0005533776267846
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HMOX1,Heme oxygenase 1,46162,125,0.60 [0.42-0.85],0.004262283183986
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HMOX2,Heme oxygenase 2,45638,124,1.39 [1.05-1.84],0.0223179172655256
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HNMT,Histamine N-methyltransferase,46113,123,2.18 [1.65-2.88],4.9534938278377444e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HPGDS,Hematopoietic prostaglandin D synthase,45615,120,0.34 [0.22-0.53],1.1209086651893044e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HPSE,Heparanase,40073,104,1.29 [1.05-1.58],0.0137242079528025
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,39538,103,1.76 [1.19-2.60],0.0042410472083853
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HRG,Histidine-rich glycoprotein,40456,105,1.94 [1.08-3.48],0.0272005694714303
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,46483,124,2.19 [1.45-3.32],0.0002076489867805
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,39446,103,3.14 [2.09-4.72],3.9173648206096296e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,46626,123,0.58 [0.40-0.86],0.0057368300514986
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,40529,106,1.47 [1.11-1.96],0.0076943377695363
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HSPA2,Heat shock-related 70 kDa protein 2,40433,105,1.92 [1.54-2.39],4.917534404138909e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HSPB6,Heat shock protein beta-6,47097,128,5.35 [4.02-7.12],1.8535197606309707e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,46350,123,5.02 [3.66-6.89],1.6471229660808524e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HYAL1,Hyaluronidase-1,46447,121,6.73 [3.98-11.40],1.2297430359097288e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HYOU1,Hypoxia up-regulated protein 1,47267,128,8.23 [4.51-15.01],5.994096859188196e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ICAM1,Intercellular adhesion molecule 1,46502,124,3.84 [2.41-6.12],1.3607588009785804e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ICAM2,Intercellular adhesion molecule 2,47267,128,3.35 [2.02-5.53],2.448186712842006e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ICAM3,Intercellular adhesion molecule 3,47267,128,3.34 [2.01-5.53],2.8805990912552616e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ICAM4,Intercellular adhesion molecule 4,46626,123,0.58 [0.43-0.78],0.0002803951692644
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ICAM5,Intercellular adhesion molecule 5,46694,125,1.69 [1.21-2.37],0.0022748184020844
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ICOSLG,ICOS ligand,46483,124,3.73 [1.67-8.33],0.0013084252135034
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IDUA,Alpha-L-iduronidase,47097,128,3.38 [2.35-4.87],6.51123318769257e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,39482,103,2.96 [2.07-4.22],2.152190164641403e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IFNG,Interferon gamma,45833,124,1.19 [1.03-1.38],0.0151333286006551
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IFNGR1,Interferon gamma receptor 1,46900,124,3.41 [2.47-4.72],1.1151456651787217e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IFNGR2,Interferon gamma receptor 2,46337,124,1.94 [1.47-2.55],2.301968799313929e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IFNL1,Interferon lambda-1,45638,124,1.59 [1.18-2.14],0.0020382826835053
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IFNLR1,Interferon lambda receptor 1,46626,123,1.78 [1.30-2.44],0.000309854601046
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,40614,105,0.47 [0.25-0.90],0.022150449189258
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGF1R,Insulin-like growth factor 1 receptor,46483,124,3.00 [2.28-3.94],3.511070987897551e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGF2R,Cation-independent mannose-6-phosphate receptor,46698,127,7.49 [4.45-12.60],3.5178696480590784e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGFBP2,Insulin-like growth factor-binding protein 2,47191,127,1.86 [1.45-2.40],1.1781827846044243e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGFBP3,Insulin-like growth factor-binding protein 3,46888,125,0.32 [0.23-0.44],7.057651631277951e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGFBP4,Insulin-like growth factor-binding protein 4,46101,125,3.65 [3.06-4.35],3.0888051256546073e-47
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGFBP6,Insulin-like growth factor-binding protein 6,46496,124,3.64 [2.68-4.96],2.0096438396038562e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGFBP7,Insulin-like growth factor-binding protein 7,47267,128,2.29 [1.88-2.78],1.3240413682330566e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGFBPL1,Insulin-like growth factor-binding protein-like 1,46694,125,5.02 [3.67-6.87],7.340394001634939e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGLC2,Immunoglobulin lambda constant 2,40613,105,2.42 [1.81-3.25],3.66875493539735e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGSF3,Immunoglobulin superfamily member 3,46483,124,2.91 [2.38-3.55],7.41690856952447e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGSF8,Immunoglobulin superfamily member 8,46694,125,4.76 [3.61-6.27],1.429332837889519e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGSF9,Protein turtle homolog A,40628,107,1.76 [1.45-2.15],1.5087229220067817e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL10,Interleukin-10,45833,124,1.40 [1.22-1.61],2.981996772981469e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL10RB,Interleukin-10 receptor subunit beta,46900,124,3.76 [3.03-4.67],2.8062559670483655e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL12A_IL12B,Interleukin-12,46483,124,2.14 [1.81-2.52],9.863784639451492e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL12B,Interleukin-12 subunit beta,47210,127,2.62 [2.01-3.42],1.327069365549323e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL12RB1,Interleukin-12 receptor subunit beta-1,45833,124,2.97 [2.45-3.61],5.331553165014272e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL12RB2,Interleukin-12 receptor subunit beta-2,39446,103,2.07 [1.48-2.89],2.013323199709141e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL15,Interleukin-15,46626,123,2.30 [1.49-3.55],0.0001793521899114
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL15RA,Interleukin-15 receptor subunit alpha,45833,124,3.94 [2.57-6.03],2.9218277413464653e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL16,Pro-interleukin-16,47210,127,1.54 [1.12-2.13],0.0079082461749065
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL17C,Interleukin-17C,45833,124,1.63 [1.41-1.88],3.483136438623354e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL17D,Interleukin-17D,45833,124,1.40 [1.01-1.93],0.0445628275052456
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL18,Interleukin-18,46512,123,2.59 [1.99-3.38],2.181058537376309e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL18BP,Interleukin-18-binding protein,46888,125,7.58 [5.41-10.63],7.151796456966101e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL18R1,Interleukin-18 receptor 1,47210,127,8.36 [5.62-12.44],1.0183214637801551e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL19,Interleukin-19,45516,120,1.75 [1.51-2.04],2.8438899316854725e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL1R1,Interleukin-1 receptor type 1,46618,126,3.11 [2.28-4.24],7.969439431386168e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL1R2,Interleukin-1 receptor type 2,46593,123,8.97 [4.06-19.83],5.921194146932245e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL1RL1,Interleukin-1 receptor-like 1,47110,128,3.14 [2.25-4.38],1.87057636718224e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL1RN,Interleukin-1 receptor antagonist protein,46595,124,2.12 [1.76-2.56],5.390352380578192e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL22,Interleukin-22,40433,105,1.58 [1.28-1.96],2.838528844991103e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL2RA,Interleukin-2 receptor subunit alpha,46359,127,2.78 [2.30-3.37],4.515125221800066e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL32,Interleukin-32,46626,123,1.48 [1.07-2.05],0.0186194211467894
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL33,Interleukin-33,45833,124,1.71 [1.16-2.51],0.006941044727526
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL36G,Interleukin-36 gamma,39286,103,1.28 [1.04-1.57],0.02123874567566
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL4R,Interleukin-4 receptor subunit alpha,46626,123,3.15 [2.36-4.22],8.381342863670866e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL5RA,Interleukin-5 receptor subunit alpha,46626,123,1.57 [1.24-1.99],0.0002050494158203
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL6,Interleukin-6,46483,124,1.54 [1.35-1.76],2.1201436350957887e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL6R,Interleukin-6 receptor subunit alpha,46424,124,1.93 [1.21-3.08],0.0058310043341675
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL6ST,Interleukin-6 receptor subunit beta,46694,125,5.04 [3.32-7.67],4.0954261138912285e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL7R,Interleukin-7 receptor subunit alpha,46698,127,0.72 [0.53-0.96],0.0246796641116814
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IMMT,MICOS complex subunit MIC60,40433,105,2.58 [2.09-3.20],2.958613510840329e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IMPG1,Interphotoreceptor matrix proteoglycan 1,39312,102,0.43 [0.20-0.91],0.0266757643650271
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,INHBB,Inhibin beta B chain,39729,105,2.43 [1.79-3.29],1.0370368112263794e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,INHBC,Inhibin beta C chain,46698,127,4.43 [2.87-6.85],2.0752023664622624e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",46483,124,1.19 [1.01-1.41],0.0340142102693073
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,INSL3,Insulin-like 3,40529,106,0.75 [0.61-0.93],0.0071626501749524
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,INSL4,Early placenta insulin-like peptide,40433,105,1.60 [1.31-1.96],4.492692672624798e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,INSL5,Insulin-like peptide INSL5,40451,106,1.50 [1.27-1.79],3.1379350426730434e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,INSR,Insulin receptor,39446,103,7.21 [3.94-13.20],1.4789200979239114e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IQGAP2,Ras GTPase-activating-like protein IQGAP2,46483,124,1.61 [1.23-2.12],0.000571135694634
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",45838,124,1.21 [1.02-1.42],0.025931174579137
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGA11,Integrin alpha-11,46626,123,0.39 [0.25-0.61],2.993286186919369e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGA2,Integrin alpha-2,39729,105,0.57 [0.34-0.97],0.0374159777373375
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGA5,Integrin alpha-5,46698,127,8.52 [4.89-14.82],3.5647431110741184e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGAL,Integrin alpha-L,39446,103,2.19 [1.37-3.51],0.0011271674825847
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGAM,Integrin alpha-M,46698,127,2.10 [1.31-3.39],0.00223777219203
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGAV,Integrin alpha-V,47097,128,0.41 [0.24-0.69],0.0007979257903275
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGB1,Integrin beta-1,46655,125,2.48 [1.25-4.90],0.00930925838543
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGB2,Integrin beta-2,46408,124,3.69 [2.38-5.72],5.050806067219787e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGB6,Integrin beta-6,45833,124,3.21 [1.91-5.38],9.983676047927613e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGB7,Integrin beta-7,47097,128,2.45 [1.85-3.25],4.6867034634147e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGBL1,Integrin beta-like protein 1,40614,105,3.88 [3.05-4.95],5.689997570588507e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,46888,125,4.41 [2.92-6.65],1.5844623309257632e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,40433,105,1.42 [1.05-1.92],0.0231205863012862
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,JAM2,Junctional adhesion molecule B,47117,128,4.87 [3.38-7.02],2.3234309133590158e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,JAM3,Junctional adhesion molecule C,39729,105,1.97 [1.47-2.64],5.504178546005905e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,JCHAIN,Immunoglobulin J chain,45833,124,1.41 [1.09-1.82],0.0082451766953306
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,JUN,Transcription factor AP-1,45833,124,1.39 [1.08-1.79],0.0097980044679302
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,46483,124,2.30 [1.59-3.33],9.500990331929708e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KAZN,Kazrin,40451,106,1.21 [1.01-1.44],0.0382955786528473
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KCNC4,Potassium voltage-gated channel subfamily C member 4,39312,102,1.33 [1.01-1.74],0.0392893307522992
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KCTD5,BTB/POZ domain-containing protein KCTD5,39762,105,1.69 [1.23-2.32],0.0010806749934471
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIF1C,Kinesin-like protein KIF1C,39283,102,1.99 [1.53-2.61],4.403994206363277e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIF22,Kinesin-like protein KIF22,39283,102,1.21 [1.03-1.43],0.0201479209494355
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,40433,105,1.41 [1.15-1.73],0.0010660359810204
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,45615,120,1.35 [1.11-1.64],0.0027644936763497
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIT,Mast/stem cell growth factor receptor Kit,46810,125,0.38 [0.22-0.64],0.0003123285325915
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLK11,Kallikrein-11,46410,129,2.08 [1.67-2.60],1.0818495473322295e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLK3,Prostate-specific antigen,40614,105,0.73 [0.61-0.88],0.0010812183266867
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLK4,Kallikrein-4,47097,128,2.22 [1.95-2.52],1.7932568250431868e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLK6,Kallikrein-6,46771,128,2.01 [1.21-3.31],0.0065268338734012
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLK7,Kallikrein-7,38710,102,0.46 [0.28-0.78],0.0037318909242251
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLK8,Kallikrein-8,45148,128,1.68 [1.13-2.50],0.0101898902422214
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLRB1,Killer cell lectin-like receptor subfamily B member 1,47210,127,8.20 [5.97-11.26],1.333153994354782e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLRD1,Natural killer cells antigen CD94,47210,127,2.81 [2.05-3.86],1.8245395411013847e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLRF1,Killer cell lectin-like receptor subfamily F member 1,39446,103,1.78 [1.43-2.21],2.2793559660749097e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLRK1,NKG2-D type II integral membrane protein,40529,106,2.39 [1.91-3.00],4.838729028422266e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KRT18,"Keratin, type I cytoskeletal 18",46483,124,1.70 [1.47-1.96],4.065430982241014e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KRT19,"Keratin, type I cytoskeletal 19",46552,123,2.54 [2.14-3.01],9.005060082654295e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KRT8,"Keratin, type II cytoskeletal 8",39312,102,1.51 [1.36-1.67],1.697950432653306e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LACRT,Extracellular glycoprotein lacritin,40364,105,0.49 [0.27-0.89],0.0182113003023524
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAG3,Lymphocyte activation gene 3 protein,46483,124,2.81 [2.30-3.42],1.9097916026379423e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,46670,123,3.60 [2.89-4.48],1.4764278011396181e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,46337,124,1.34 [1.13-1.57],0.0005408379135202
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAMA4,Laminin subunit alpha-4,46900,124,1.86 [1.21-2.85],0.0043897248126899
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAMB1,Laminin subunit beta-1,39538,103,4.51 [2.43-8.39],1.872216215588384e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAMP1,Lysosome-associated membrane glycoprotein 1,39474,103,1.46 [1.06-2.00],0.0189137355577174
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAMP3,Lysosome-associated membrane glycoprotein 3,47133,127,1.85 [1.39-2.45],2.18873494218772e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAT2,Linker for activation of T-cells family member 2,46483,124,1.15 [1.01-1.30],0.0309219567532504
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAYN,Layilin,46261,123,5.59 [4.37-7.16],9.43308298551583e-43
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LBP,Lipopolysaccharide-binding protein,46888,125,1.68 [1.30-2.16],5.923536707955925e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LBR,Delta(14)-sterol reductase LBR,47117,128,1.29 [1.07-1.56],0.0075472261894057
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LCN15,Lipocalin-15,40550,105,1.72 [1.46-2.02],5.3630626284823164e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LCN2,Neutrophil gelatinase-associated lipocalin,45294,121,2.92 [2.21-3.87],7.363061974734869e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LECT2,Leukocyte cell-derived chemotaxin-2,40628,107,1.57 [1.23-2.01],0.0003505172934162
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LEFTY2,Left-right determination factor 2,47029,128,1.82 [1.35-2.44],6.98258627702112e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LEO1,RNA polymerase-associated protein LEO1,40550,105,1.63 [1.12-2.38],0.0112730750699491
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LEP,Leptin,46694,125,1.45 [1.13-1.87],0.0040689431023983
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LEPR,Leptin receptor,46694,125,1.78 [1.20-2.66],0.0044654219708884
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LETM1,Mitochondrial proton/calcium exchanger protein,40550,105,1.96 [1.52-2.53],1.6767892865142157e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LGALS1,Galectin-1,46694,125,2.54 [1.76-3.67],6.630224375846387e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LGALS3,Galectin-3,46818,125,3.47 [2.22-5.41],4.144504199110501e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LGALS3BP,Galectin-3-binding protein,40679,105,2.82 [2.04-3.92],4.758489755043605e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LGALS4,Galectin-4,46670,123,4.38 [3.61-5.31],1.6875209928092685e-50
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LGALS7_LGALS7B,Galectin-7,46566,127,1.58 [1.18-2.11],0.0020793984463517
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LGALS9,Galectin-9,46668,124,7.16 [4.90-10.44],1.8008150991506418e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LGMN,Legumain,46900,124,2.02 [1.33-3.05],0.0008887383632515
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,46750,124,0.62 [0.48-0.79],0.0001322714423546
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LIFR,Leukemia inhibitory factor receptor,46626,123,8.06 [5.85-11.11],2.7601124697648205e-37
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,46698,127,1.90 [1.20-3.00],0.0060231342914079
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,46621,125,3.70 [2.37-5.78],9.482802841449777e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,40628,107,1.55 [1.19-2.01],0.001103704240829
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,47267,128,3.96 [2.32-6.74],4.121643581136295e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,47034,127,3.12 [1.91-5.08],4.984976529411619e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,45833,124,3.20 [2.38-4.31],1.3397167183981604e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LMNB2,Lamin-B2,40529,106,3.53 [2.26-5.52],3.1798657078532937e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LMOD1,Leiomodin-1,40550,105,2.34 [1.82-3.01],4.421817056667995e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LONP1,"Lon protease homolog, mitochondrial",39538,103,1.36 [1.13-1.65],0.0015409982797453
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LPL,Lipoprotein lipase,46694,125,0.58 [0.44-0.77],0.0001057060603217
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LPO,Lactoperoxidase,45152,122,2.21 [1.74-2.81],6.562643186904156e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,39283,102,1.42 [1.11-1.81],0.0052755448374034
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRG1,Leucine-rich alpha-2-glycoprotein,40679,105,3.00 [1.58-5.68],0.0007856558657893
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,46960,128,3.11 [2.08-4.67],3.908206071579104e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,39306,103,2.25 [1.44-3.50],0.0003467511280603
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRP11,Low-density lipoprotein receptor-related protein 11,46694,125,4.86 [3.42-6.91],1.477465073253425e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRP2BP,LRP2-binding protein,39492,104,1.22 [1.02-1.45],0.03231798443815
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRRC25,Leucine-rich repeat-containing protein 25,46483,124,2.63 [1.93-3.58],7.810760870272344e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRRC37A2,Leucine-rich repeat-containing protein 37A2,40451,106,2.15 [1.42-3.26],0.0003109725376
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,40433,105,1.48 [1.05-2.09],0.0252621661472762
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRRN1,Leucine-rich repeat neuronal protein 1,45833,124,0.43 [0.29-0.63],1.562825438402015e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,40550,105,0.37 [0.17-0.81],0.0128454455269323
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LSP1,Lymphocyte-specific protein 1,46626,123,1.50 [1.03-2.20],0.0347316866921486
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LTA,Lymphotoxin-alpha,46626,123,1.60 [1.13-2.27],0.0087781650995097
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LTA4H,Leukotriene A-4 hydrolase,47097,128,0.56 [0.42-0.76],0.0001693966910689
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LTBP2,Latent-transforming growth factor beta-binding protein 2,47267,128,6.37 [4.60-8.82],7.557919395575054e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LTBP3,Latent-transforming growth factor beta-binding protein 3,45615,120,1.81 [1.50-2.19],6.230826844570272e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LTBR,Tumor necrosis factor receptor superfamily member 3,46439,123,6.07 [4.29-8.60],3.1873365732052422e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LUZP2,Leucine zipper protein 2,40433,105,1.59 [1.17-2.18],0.0033070432206804
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LXN,Latexin,46126,124,0.61 [0.47-0.80],0.0003379704707782
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LY6D,Lymphocyte antigen 6D,46445,124,2.23 [1.66-2.98],7.48009411387674e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LY75,Lymphocyte antigen 75,46626,123,1.94 [1.26-2.98],0.0026753501992715
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LY9,T-lymphocyte surface antigen Ly-9,46157,123,5.04 [3.32-7.65],2.852848339387423e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LY96,Lymphocyte antigen 96,46337,124,2.76 [2.04-3.73],4.757164642434757e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LYPD8,Ly6/PLAUR domain-containing protein 8,45615,120,1.62 [1.27-2.07],9.166390127819078e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,40679,105,4.90 [2.02-11.90],0.0004458075146732
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,46186,123,1.56 [1.29-1.89],4.4604036023599024e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAMDC2,MAM domain-containing protein 2,40628,107,3.19 [2.13-4.77],1.8931574788160138e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAMDC4,Apical endosomal glycoprotein,40433,105,1.52 [1.12-2.05],0.0068039899313351
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MANSC1,MANSC domain-containing protein 1,46850,129,5.22 [3.36-8.10],1.6465092179083913e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAP2,Microtubule-associated protein 2,40529,106,1.83 [1.41-2.38],5.479085057652952e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MARCO,Macrophage receptor MARCO,46694,125,2.58 [1.40-4.77],0.0024948058812159
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MASP1,Mannan-binding lectin serine protease 1,46261,123,2.49 [1.28-4.86],0.0072080911074943
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MATN2,Matrilin-2,46745,123,2.98 [1.78-4.96],2.887666304977801e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MATN3,Matrilin-3,46258,124,0.55 [0.34-0.91],0.0188568169629068
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAVS,Mitochondrial antiviral-signaling protein,45615,120,1.20 [1.01-1.42],0.0435445461762378
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MB,Myoglobin,47267,128,1.84 [1.48-2.29],3.899854205509765e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MCAM,Cell surface glycoprotein MUC18,46888,125,1.62 [1.01-2.58],0.0440697822914011
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MCEMP1,Mast cell-expressed membrane protein 1,39446,103,1.29 [1.06-1.56],0.0100255567917386
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MCFD2,Multiple coagulation factor deficiency protein 2,46482,125,2.08 [1.49-2.90],1.6868942402871308e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,46337,124,1.62 [1.28-2.05],5.23766998161078e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MDK,Midkine,46705,129,2.04 [1.73-2.40],2.1448822630394817e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",39538,103,1.26 [1.05-1.52],0.0153797446116352
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MEGF10,Multiple epidermal growth factor-like domains protein 10,46670,123,2.14 [1.43-3.19],0.0001976149853115
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MEGF9,Multiple epidermal growth factor-like domains protein 9,47110,128,2.10 [1.18-3.71],0.0110729705928729
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MENT,Protein MENT,39729,105,0.40 [0.28-0.57],4.425826563143482e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MEPE,Matrix extracellular phosphoglycoprotein,46670,123,0.39 [0.22-0.66],0.0005753558082976
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MERTK,Tyrosine-protein kinase Mer,47210,127,2.17 [1.20-3.93],0.0106375212199273
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MET,Hepatocyte growth factor receptor,46813,124,0.37 [0.16-0.84],0.0167011264715284
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",46626,123,1.21 [1.01-1.45],0.0440452022780124
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MFAP4,Microfibril-associated glycoprotein 4,39729,105,7.77 [4.52-13.34],1.111225821039832e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MFAP5,Microfibrillar-associated protein 5,47267,128,1.77 [1.21-2.59],0.0031892792147414
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MFGE8,Lactadherin,46698,127,4.22 [3.18-5.59],1.2408352672624493e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,46626,123,1.26 [1.07-1.48],0.0046224629101558
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MILR1,Allergin-1,45833,124,2.52 [1.95-3.25],1.5541127470319698e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MLN,Promotilin,46626,123,1.78 [1.47-2.15],2.370913943551512e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MME,Neprilysin,46483,124,1.68 [1.40-2.01],1.5409273603367248e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MMP1,Interstitial collagenase,44988,120,1.30 [1.08-1.57],0.0066068291735946
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MMP10,Stromelysin-2,46591,123,1.95 [1.56-2.43],3.5289959543589127e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MMP12,Macrophage metalloelastase,46734,128,2.65 [2.10-3.35],2.382023630483881e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MMP3,Stromelysin-1,46698,127,1.58 [1.20-2.09],0.0012597530962312
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MMP7,Matrilysin,45765,124,3.97 [2.92-5.40],1.7665986157359942e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MMP8,Neutrophil collagenase,47039,128,1.27 [1.04-1.56],0.0220076185057917
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MMP9,Matrix metalloproteinase-9,46620,127,1.31 [1.01-1.71],0.0422022416910229
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MOCS2,Molybdopterin synthase catalytic subunit,39729,105,1.40 [1.08-1.83],0.0125050611981918
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MRC1,Macrophage mannose receptor 1,40646,105,8.51 [5.20-13.91],1.5012434242488386e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MSLN,Mesothelin,46414,124,1.83 [1.45-2.31],3.139049217136411e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MSMB,Beta-microseminoprotein,46576,125,1.42 [1.16-1.74],0.000790777941506
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MSR1,Macrophage scavenger receptor types I and II,47117,128,3.89 [2.96-5.11],2.4734007375807435e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MST1,Hepatocyte growth factor-like protein,40031,104,1.54 [1.01-2.37],0.0469813896207818
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MTDH,Protein LYRIC,39446,103,1.28 [1.06-1.55],0.0103820510426617
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MTSS1,Protein MTSS 1,40451,106,1.22 [1.04-1.44],0.0174353958337224
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MTUS1,Microtubule-associated tumor suppressor 1,39882,107,1.46 [1.10-1.93],0.0085686452177602
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MUC13,Mucin-13,45638,124,4.74 [3.97-5.65],7.662676569544941e-67
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MUCL3,Mucin-like protein 3,39172,104,1.50 [1.15-1.96],0.0026157993545649
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MVK,Mevalonate kinase,45833,124,1.66 [1.41-1.96],2.200507223254608e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MXRA8,Matrix remodeling-associated protein 8,39729,105,0.54 [0.39-0.75],0.0002184898387171
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYBPC1,"Myosin-binding protein C, slow-type",40628,107,2.04 [1.69-2.46],1.1259627322780797e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYBPC2,"Myosin-binding protein C, fast-type",39538,103,1.36 [1.16-1.60],0.0001441732589441
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYDGF,Myeloid-derived growth factor,40628,107,1.29 [1.08-1.55],0.0058452146968784
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",39283,102,1.48 [1.18-1.87],0.000824085520518
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYL3,Myosin light chain 3,39538,103,1.93 [1.54-2.41],1.1944829726510464e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",39492,104,1.72 [1.40-2.12],4.00249739313813e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYOM2,Myomesin-2,39283,102,1.56 [1.17-2.08],0.0022934135498438
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYOM3,Myomesin-3,39729,105,1.47 [1.22-1.77],5.523230931151873e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MZB1,Marginal zone B- and B1-cell-specific protein,46822,123,1.92 [1.47-2.51],1.6273409584575738e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NACC1,Nucleus accumbens-associated protein 1,40433,105,1.33 [1.00-1.77],0.0497745539184322
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NAGA,Alpha-N-acetylgalactosaminidase,39374,102,1.34 [1.04-1.73],0.0254026386766147
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NAGK,N-acetyl-D-glucosamine kinase,39467,103,0.62 [0.44-0.89],0.0086928661295153
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,39729,105,4.21 [1.86-9.55],0.0005762571037824
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NBL1,Neuroblastoma suppressor of tumorigenicity 1,46850,129,10.15 [6.69-15.40],1.169631019766775e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NCAN,Neurocan core protein,47117,128,0.47 [0.37-0.58],1.2255267771891388e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NCR1,Natural cytotoxicity triggering receptor 1,46558,123,4.78 [3.39-6.74],4.705123588882262e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,40451,106,4.82 [3.37-6.90],7.527272500378581e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NCS1,Neuronal calcium sensor 1,47097,128,6.18 [3.83-9.98],9.454176606149446e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,39381,103,2.01 [1.26-3.22],0.0034890909086273
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,40451,106,1.23 [1.01-1.49],0.039967227084887
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",45615,120,1.28 [1.11-1.49],0.0008908172235805
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NECTIN2,Nectin-2,46621,125,8.44 [6.19-11.51],1.9410246338582188e-41
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NECTIN4,Nectin-4,46850,129,3.46 [2.69-4.45],4.254428976381277e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NEFL,Neurofilament light polypeptide,45494,123,2.61 [2.13-3.19],7.809790174621492e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NELL1,Protein kinase C-binding protein NELL1,46850,129,0.55 [0.44-0.68],9.850110182301224e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NEO1,Neogenin,40550,105,1.97 [1.09-3.54],0.0238819703582406
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NFASC,Neurofascin,47210,127,25.61 [16.93-38.73],2.9832670430990063e-53
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",45833,124,1.78 [1.45-2.17],1.6332500418234033e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NFKBIE,NF-kappa-B inhibitor epsilon,45615,120,1.35 [1.01-1.81],0.0423041512491351
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",40451,106,1.20 [1.01-1.43],0.0394958955943491
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NGFR,Tumor necrosis factor receptor superfamily member 16,40628,107,2.32 [1.76-3.06],2.556767388195904e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NGRN,Neugrin,40529,106,3.32 [2.25-4.90],1.619517154812514e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NHLRC3,NHL repeat-containing protein 3,38778,103,7.02 [3.97-12.42],2.150596893142325e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NINJ1,Ninjurin-1,45615,120,1.32 [1.05-1.66],0.018093603710344
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NOMO1,Nodal modulator 1,46698,127,4.31 [2.60-7.16],1.6437781760884774e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NOS1,"Nitric oxide synthase, brain",45638,124,2.10 [1.74-2.53],1.448433993583731e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NOS3,"Nitric oxide synthase, endothelial",45638,124,1.74 [1.49-2.02],1.1695994720114137e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NOTCH1,Neurogenic locus notch homolog protein 1,47267,128,13.25 [5.66-31.05],2.7114133204385742e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NOTCH2,Neurogenic locus notch homolog protein 2,40614,105,3.96 [1.99-7.88],8.60126146540607e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NOTCH3,Neurogenic locus notch homolog protein 3,47267,128,1.60 [1.02-2.50],0.0389633381635017
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPDC1,Neural proliferation differentiation and control protein 1,46694,125,3.76 [2.96-4.78],2.038934283043845e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPL,N-acetylneuraminate lyase,40628,107,1.64 [1.13-2.38],0.0088956754301202
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPPB,Natriuretic peptides B,45838,124,1.43 [1.28-1.59],3.074249078671678e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPPC,C-type natriuretic peptide,46626,123,1.38 [1.07-1.78],0.0145456072547295
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPTN,Neuroplastin,45615,120,1.18 [1.00-1.39],0.0443867248053499
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPTX1,Neuronal pentraxin-1,46698,127,1.60 [1.13-2.26],0.0078735863726632
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPY,Pro-neuropeptide Y,47097,128,3.98 [3.02-5.26],1.5981024235940212e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NRCAM,Neuronal cell adhesion molecule,46694,125,5.02 [3.57-7.06],1.920443284657624e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NRP1,Neuropilin-1,46966,125,6.21 [3.72-10.35],2.806570860222499e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NT5C1A,Cytosolic 5'-nucleotidase 1A,40529,106,2.43 [1.97-2.98],3.9427948887399867e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NT5E,5'-nucleotidase,46850,129,1.36 [1.05-1.78],0.0209940747989919
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NTF3,Neurotrophin-3,46626,123,2.62 [1.90-3.61],4.549337059385802e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NTRK3,NT-3 growth factor receptor,47117,128,0.51 [0.34-0.75],0.0007973027764639
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NTproBNP,N-terminal prohormone of brain natriuretic peptide,46694,125,1.62 [1.45-1.80],1.3036765448612988e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NUCB2,Nucleobindin-2,47019,128,2.77 [1.92-4.00],5.3172782408920864e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NUDC,Nuclear migration protein nudC,47210,127,1.33 [1.03-1.72],0.0286106365412189
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NUDT16,U8 snoRNA-decapping enzyme,40381,106,1.27 [1.03-1.55],0.0225471105647915
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],46483,124,0.69 [0.51-0.94],0.0177892673590369
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OCLN,Occludin,40550,105,3.16 [2.45-4.06],4.0887552657398e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ODAM,Odontogenic ameloblast-associated protein,45560,124,0.71 [0.51-0.98],0.0399321161664622
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OGN,Mimecan,46698,127,3.23 [2.44-4.27],3.209577984436487e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OLFM4,Olfactomedin-4,38252,100,1.40 [1.18-1.66],8.7875656724896e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OMD,Osteomodulin,46900,124,0.33 [0.24-0.46],3.475106015837533e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OMG,Oligodendrocyte-myelin glycoprotein,46483,124,0.61 [0.49-0.77],2.3624936981213944e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OPLAH,5-oxoprolinase,39538,103,1.38 [1.05-1.80],0.0195679788495748
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ORM1,Alpha-1-acid glycoprotein 1,40533,105,2.51 [1.05-5.99],0.0374957751375061
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OSCAR,Osteoclast-associated immunoglobulin-like receptor,46745,123,4.22 [2.67-6.65],6.428464506786882e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OSM,Oncostatin-M,46402,122,1.34 [1.07-1.68],0.0110005789419887
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OSMR,Oncostatin-M-specific receptor subunit beta,46966,125,6.69 [3.14-14.28],8.605179274467746e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OTUD7B,OTU domain-containing protein 7B,40550,105,1.50 [1.13-1.98],0.0046172592934163
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OXT,Oxytocin-neurophysin 1,47117,128,1.27 [1.14-1.42],3.092508997215965e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,P4HB,Protein disulfide-isomerase,46480,129,2.08 [1.42-3.05],0.0001733461168584
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PACS2,Phosphofurin acidic cluster sorting protein 2,39283,102,1.36 [1.02-1.81],0.0375641432302418
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PADI2,Protein-arginine deiminase type-2,45833,124,1.27 [1.01-1.59],0.0412092655090262
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,45838,124,1.63 [1.28-2.08],6.536673121842532e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PALM,Paralemmin-1,40232,106,3.23 [2.43-4.31],1.112932897504835e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PALM2,Paralemmin-2,40529,106,3.83 [3.02-4.85],1.1012008313622098e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PAMR1,Inactive serine protease PAMR1,46698,127,1.80 [1.00-3.24],0.0498909885217946
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,40451,106,1.95 [1.30-2.93],0.0012627252704805
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,39653,105,1.44 [1.01-2.04],0.0419228023573049
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PCDH1,Protocadherin-1,47063,127,2.65 [1.57-4.47],0.0002761543909348
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PCDH17,Protocadherin-17,46694,125,3.25 [2.56-4.12],3.3879589405428123e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PCDH7,Protocadherin-7,40451,106,1.84 [1.36-2.50],7.992055748947328e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PCDH9,Protocadherin-9,40451,106,2.62 [1.53-4.47],0.0004178566452305
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PCDHB15,Protocadherin beta-15,40433,105,1.65 [1.12-2.43],0.0120795187338716
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PCSK9,Proprotein convertase subtilisin/kexin type 9,47267,128,2.70 [1.86-3.90],1.3800088631941462e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDCD1,Programmed cell death protein 1,47019,128,2.60 [2.03-3.33],3.3502466102499134e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDCD1LG2,Programmed cell death 1 ligand 2,46483,124,3.14 [2.42-4.07],6.234650481751248e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDCD6,Programmed cell death protein 6,46694,125,1.54 [1.14-2.06],0.0045307820749166
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDGFC,Platelet-derived growth factor C,45615,120,1.74 [1.02-2.97],0.0434766130218286
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDGFRA,Platelet-derived growth factor receptor alpha,46694,125,5.58 [3.66-8.51],1.3589371465681433e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDIA3,Protein disulfide-isomerase A3,39729,105,2.71 [1.93-3.80],9.872371620775025e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDIA4,Protein disulfide-isomerase A4,40614,105,1.33 [1.01-1.76],0.0446330949316383
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDZD2,PDZ domain-containing protein 2,39283,102,1.35 [1.02-1.79],0.0348546568032058
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,39446,103,2.56 [1.97-3.33],1.637539076953943e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PEAR1,Platelet endothelial aggregation receptor 1,47267,128,3.67 [1.87-7.21],0.0001600914982282
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PECAM1,Platelet endothelial cell adhesion molecule,46698,127,1.76 [1.09-2.85],0.0207292571245734
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PENK,Proenkephalin-A,39729,105,2.54 [1.88-3.43],1.3719889496753174e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PEPD,Xaa-Pro dipeptidase,40646,105,0.33 [0.16-0.66],0.001711232536899
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PGA4,Pepsin A-4,40646,105,1.47 [1.16-1.86],0.0013390206488245
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PGF,Placenta growth factor,47210,127,4.24 [3.38-5.33],2.0610349743641127e-35
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PGLYRP1,Peptidoglycan recognition protein 1,47034,127,2.31 [1.75-3.05],4.091365854942395e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,40159,105,2.14 [1.10-4.16],0.0251931730579578
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PHLDB1,Pleckstrin homology-like domain family B member 1,40451,106,2.14 [1.57-2.92],1.722906179143217e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,46337,124,4.09 [3.03-5.51],2.6600874170044602e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PI3,Elafin,46066,125,2.03 [1.69-2.45],1.087587187688356e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PIGR,Polymeric immunoglobulin receptor,46097,126,6.08 [4.61-8.03],2.346642962301514e-37
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,46698,127,0.37 [0.20-0.70],0.002320466020693
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PILRA,Paired immunoglobulin-like type 2 receptor alpha,46698,127,4.79 [3.49-6.58],3.750341508821386e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PILRB,Paired immunoglobulin-like type 2 receptor beta,46694,125,3.36 [2.43-4.64],1.8254712391792565e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,39729,105,0.62 [0.49-0.79],0.0001046480915152
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PKD1,Polycystin-1,40628,107,12.81 [6.92-23.73],5.157439945907432e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PKD2,Polycystin-2,39283,102,1.68 [1.31-2.14],3.1870423389560144e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PKLR,Pyruvate kinase PKLR,46747,124,0.69 [0.53-0.89],0.0044569155093657
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLA2G10,Group 10 secretory phospholipase A2,46337,124,1.83 [1.39-2.39],1.1512217911358087e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLA2G15,Phospholipase A2 group XV,46850,129,5.51 [3.41-8.92],3.402351349935612e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLA2G1B,Phospholipase A2,47189,128,0.67 [0.47-0.95],0.0233634964298027
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLA2G2A,"Phospholipase A2, membrane associated",46598,125,1.40 [1.17-1.68],0.000318483534341
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLA2G7,Platelet-activating factor acetylhydrolase,46698,127,0.54 [0.41-0.71],8.869605985752493e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLAU,Urokinase-type plasminogen activator,46698,127,1.51 [1.02-2.22],0.0387537795275614
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLAUR,Urokinase plasminogen activator surface receptor,46358,123,12.99 [8.83-19.11],8.283974976239528e-39
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLB1,"Phospholipase B1, membrane-associated",40529,106,0.55 [0.41-0.75],0.0001031928720213
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLEKHO1,Pleckstrin homology domain-containing family O member 1,40529,106,1.49 [1.17-1.91],0.0012284843598342
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLIN1,Perilipin-1,45638,124,1.77 [1.29-2.42],0.0003409008174765
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLIN3,Perilipin-3,46694,125,1.98 [1.43-2.74],3.634793459222728e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLSCR3,Phospholipid scramblase 3,40457,106,1.79 [1.32-2.43],0.0001973277372347
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLXDC2,Plexin domain-containing protein 2,40529,106,2.17 [1.53-3.07],1.3225798694898374e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLXNB2,Plexin-B2,47037,127,33.26 [22.94-48.23],2.6459956311575407e-76
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PNLIPRP1,Inactive pancreatic lipase-related protein 1,40529,106,1.37 [1.11-1.71],0.0041477602818206
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,POF1B,Protein POF1B,39446,103,2.23 [1.84-2.70],3.210635065608566e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",46483,124,1.75 [1.33-2.31],6.881510057414334e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PON1,Serum paraoxonase/arylesterase 1,40646,105,0.38 [0.27-0.54],6.18547047045955e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PON2,Serum paraoxonase/arylesterase 2,45838,124,1.57 [1.01-2.43],0.0430943531362621
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PON3,Serum paraoxonase/lactonase 3,46900,124,0.39 [0.33-0.45],3.935704482505396e-36
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPL,Periplakin,39446,103,1.90 [1.26-2.87],0.0021636723992986
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPM1A,Protein phosphatase 1A,45615,120,0.48 [0.26-0.88],0.0171632445485259
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPME1,Protein phosphatase methylesterase 1,46483,124,0.76 [0.59-0.99],0.0445600687829272
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,39882,107,1.34 [1.11-1.62],0.001983322549975
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,40550,105,2.02 [1.48-2.75],8.174491625066359e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,40451,106,1.17 [1.01-1.35],0.0364074146936332
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPY,Pancreatic prohormone,46639,129,1.58 [1.37-1.82],2.9379385686829343e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRAP1,Proline-rich acidic protein 1,40614,105,23.78 [14.52-38.93],2.197352500718132e-36
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRCP,Lysosomal Pro-X carboxypeptidase,46970,128,4.48 [3.57-5.63],3.415543350207201e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRDX2,Peroxiredoxin-2,39951,102,0.51 [0.37-0.72],9.656732210725592e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",45833,124,1.32 [1.07-1.63],0.0087190701704181
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRDX6,Peroxiredoxin-6,47097,128,0.54 [0.41-0.71],8.645088326219319e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PREB,Prolactin regulatory element-binding protein,45833,124,2.34 [1.73-3.18],4.909774762509049e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRELP,Prolargin,46670,123,4.45 [2.87-6.89],2.310431770484852e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRG2,Bone marrow proteoglycan,40614,105,2.39 [1.73-3.29],1.1447375710924136e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,45833,124,1.43 [1.09-1.87],0.0094459049634645
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,40453,106,1.29 [1.01-1.64],0.0406416150758812
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,45615,120,1.35 [1.09-1.68],0.0067258457841725
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRND,Prion-like protein doppel,40529,106,1.40 [1.03-1.91],0.0308658012730384
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRR4,Proline-rich protein 4,39442,105,1.43 [1.13-1.81],0.0029418318875895
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRRT3,Proline-rich transmembrane protein 3,39538,103,2.57 [1.64-4.03],4.2137373593053344e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRSS2,Trypsin-2,46888,125,1.51 [1.17-1.94],0.0012885801232859
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRSS22,Brain-specific serine protease 4,39446,103,2.09 [1.71-2.54],3.287217135643275e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRSS27,Serine protease 27,46538,125,1.96 [1.33-2.89],0.0006553136325496
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRSS8,Prostasin,46516,124,6.77 [5.06-9.06],7.698250702119092e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRTG,Protogenin,47097,128,3.46 [2.35-5.09],2.7012711116691747e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRTN3,Myeloblastin,45519,125,1.54 [1.21-1.98],0.0005445788975355
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRUNE2,Protein prune homolog 2,39882,107,2.07 [1.32-3.23],0.0014125021891256
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSAP,Prosaposin,40226,105,2.99 [2.28-3.92],3.258637106559498e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSG1,Pregnancy-specific beta-1-glycoprotein 1,46337,124,1.87 [1.56-2.25],2.132103798382457e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSMD9,26S proteasome non-ATPase regulatory subunit 9,46483,124,0.61 [0.44-0.84],0.0026056103770844
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSMG3,Proteasome assembly chaperone 3,46626,123,0.68 [0.50-0.94],0.0211867119176321
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSRC1,Proline/serine-rich coiled-coil protein 1,45615,120,1.33 [1.06-1.66],0.0130232049432669
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTGDS,Prostaglandin-H2 D-isomerase,46354,124,5.02 [3.77-6.67],1.9530126776726422e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTGES2,Prostaglandin E synthase 2,39147,101,1.55 [1.15-2.10],0.0041109515936577
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTGR1,Prostaglandin reductase 1,40628,107,1.26 [1.03-1.54],0.027998123902881
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,46626,123,1.71 [1.34-2.18],1.4397577518201584e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTK7,Inactive tyrosine-protein kinase 7,45638,124,2.62 [1.86-3.71],4.216303098127329e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTP4A3,Protein tyrosine phosphatase type IVA 3,39446,103,1.42 [1.06-1.89],0.0170366507664747
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,39370,103,1.55 [1.10-2.20],0.013416420800479
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTPRB,Receptor-type tyrosine-protein phosphatase beta,40628,107,3.03 [1.84-4.99],1.248362498751418e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTPRC,Receptor-type tyrosine-protein phosphatase C,40614,105,3.94 [2.38-6.50],8.946986800472503e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTPRH,Receptor-type tyrosine-protein phosphatase H,40451,106,1.87 [1.32-2.67],0.0004885869748103
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,40451,106,2.17 [1.45-3.27],0.0001861916090696
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTPRM,Receptor-type tyrosine-protein phosphatase mu,46552,122,2.01 [1.04-3.86],0.0370235652652343
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,46183,123,2.79 [1.92-4.06],8.435887706500926e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTS,6-pyruvoyl tetrahydrobiopterin synthase,45422,123,1.50 [1.18-1.90],0.0010600294847865
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTX3,Pentraxin-related protein PTX3,46626,123,2.15 [1.42-3.25],0.0002895524048296
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PVR,Poliovirus receptor,47117,128,4.02 [2.96-5.44],2.640282292755113e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PYY,Peptide YY,39283,102,2.33 [2.00-2.71],2.0756580599744118e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PZP,Pregnancy zone protein,40679,105,0.51 [0.32-0.81],0.0045295636081144
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,QPCT,Glutaminyl-peptide cyclotransferase,46737,127,5.88 [3.93-8.80],6.270546323108205e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,QSOX1,Sulfhydryl oxidase 1,39866,103,1.72 [1.39-2.12],4.852408209210949e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RAB6A,Ras-related protein Rab-6A,46626,123,0.42 [0.30-0.59],3.480096856123412e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RARRES1,Retinoic acid receptor responder protein 1,45615,120,1.60 [1.23-2.10],0.000589674019955
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RARRES2,Retinoic acid receptor responder protein 2,46966,125,2.05 [1.66-2.53],2.339478526779312e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RBFOX3,RNA binding protein fox-1 homolog 3,40550,105,3.71 [2.23-6.18],4.667376473672385e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RBKS,Ribokinase,45597,120,0.67 [0.51-0.88],0.0046657058177756
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RBP2,Retinol-binding protein 2,46483,124,1.74 [1.45-2.10],5.4070991007311294e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RBP5,Retinol-binding protein 5,46483,124,2.52 [2.01-3.14],4.530359704704054e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RBP7,Retinoid-binding protein 7,40451,106,1.68 [1.34-2.10],6.0291581813159954e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,REG1A,Lithostathine-1-alpha,46424,123,3.24 [2.71-3.86],1.2542035115122932e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,REG1B,Lithostathine-1-beta,47267,128,2.40 [2.00-2.87],1.305863987806327e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,REG3A,Regenerating islet-derived protein 3-alpha,47267,128,2.27 [1.88-2.73],6.030473426372343e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,REG4,Regenerating islet-derived protein 4,46745,123,5.17 [4.10-6.53],9.533572665580473e-44
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RELT,Tumor necrosis factor receptor superfamily member 19L,46698,127,4.52 [3.26-6.28],2.1611219962627825e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,REN,Renin,46694,125,2.56 [2.27-2.89],3.242012573840291e-52
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,46483,124,2.03 [1.36-3.05],0.000576901807774
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RETN,Resistin,46576,124,2.45 [1.89-3.17],1.234957625944916e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RFC4,Replication factor C subunit 4,40433,105,2.10 [1.06-4.14],0.0324369319414594
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,39882,107,1.27 [1.02-1.60],0.0349011271683714
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RGMB,RGM domain family member B,47117,128,2.81 [1.69-4.68],7.08646649783495e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,39729,105,1.48 [1.07-2.05],0.0169514146408897
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNASE1,Ribonuclease pancreatic,40646,105,4.30 [3.44-5.39],4.364440245035702e-37
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNASE10,Inactive ribonuclease-like protein 10,39538,103,1.98 [1.60-2.44],2.0703583510240167e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNASE4,Ribonuclease 4,39311,100,4.27 [3.05-5.99],4.119576095427857e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNASE6,Ribonuclease K6,40361,104,2.52 [2.13-2.98],1.337804849510304e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNASET2,Ribonuclease T2,47038,128,7.01 [5.26-9.34],2.5467189201114833e-40
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNF149,E3 ubiquitin-protein ligase RNF149,39538,103,3.73 [2.99-4.64],9.96932658908504e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ROBO1,Roundabout homolog 1,46745,123,5.02 [3.33-7.58],1.5794433258351718e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,46694,125,2.62 [1.65-4.17],4.3597202602580176e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RRM2,Ribonucleoside-diphosphate reductase subunit M2,45615,120,1.45 [1.16-1.82],0.0012391623690522
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RSPO1,R-spondin-1,46337,124,1.76 [1.18-2.63],0.0054022649675541
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RSPO3,R-spondin-3,47097,128,3.57 [2.38-5.35],7.211360887369362e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RTBDN,Retbindin,46483,124,1.77 [1.20-2.62],0.003879991900733
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RTN4R,Reticulon-4 receptor,47097,128,3.75 [3.14-4.47],3.855917092859859e-49
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,S100A13,Protein S100-A13,39446,103,1.61 [1.06-2.45],0.0246421261820243
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,S100A14,Protein S100-A14,40550,105,0.56 [0.37-0.85],0.0062300637065855
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,S100A3,Protein S100-A3,40433,105,1.38 [1.06-1.79],0.0163735426883638
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,S100P,Protein S100-P,45838,124,1.53 [1.23-1.91],0.0001208417144319
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SARG,Specifically androgen-regulated gene protein,40470,107,1.22 [1.03-1.45],0.0206269259665712
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SAT2,Thialysine N-epsilon-acetyltransferase,39882,107,1.30 [1.04-1.64],0.0229204561640437
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCAMP3,Secretory carrier-associated membrane protein 3,46483,124,1.40 [1.17-1.67],0.0002685508036199
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCARA5,Scavenger receptor class A member 5,47117,128,7.55 [5.27-10.83],4.065330474664746e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCARB1,Scavenger receptor class B member 1,45638,124,1.37 [1.12-1.67],0.0022373504660953
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCARB2,Lysosome membrane protein 2,45454,123,4.56 [3.69-5.63],8.540377277955587e-45
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCARF1,Scavenger receptor class F member 1,47267,128,2.50 [1.78-3.51],1.055665103406582e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCARF2,Scavenger receptor class F member 2,47117,128,7.11 [4.75-10.63],1.3350024715809618e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCG2,Secretogranin-2,46882,128,9.81 [6.70-14.36],7.321161813845182e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCGB1A1,Uteroglobin,46746,124,1.51 [1.13-2.03],0.0059876380028719
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCGB3A1,Secretoglobin family 3A member 1,39729,105,2.13 [1.03-4.39],0.0417009530794003
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCGB3A2,Secretoglobin family 3A member 2,46823,124,1.30 [1.14-1.50],0.0001546082741941
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCGN,Secretagogin,45833,124,3.09 [2.39-3.99],8.49178609553001e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCLY,Selenocysteine lyase,46960,128,1.62 [1.19-2.21],0.0021194997397346
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCN4B,Sodium channel subunit beta-4,39538,103,2.25 [1.50-3.37],9.01265157559116e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCPEP1,Retinoid-inducible serine carboxypeptidase,39389,103,1.80 [1.29-2.50],0.0005326254476137
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCRG1,Scrapie-responsive protein 1,40628,107,2.61 [1.80-3.80],4.973485072495251e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SDC1,Syndecan-1,46694,125,2.70 [2.03-3.60],8.833211217222106e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SDC4,Syndecan-4,46694,125,0.56 [0.41-0.77],0.0003773413046766
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SDCCAG8,Serologically defined colon cancer antigen 8,40433,105,1.19 [1.01-1.40],0.0356123705756457
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SDHB,Succinate dehydrogenase,40451,106,1.29 [1.01-1.64],0.0406932938924411
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEL1L,Protein sel-1 homolog 1,39538,103,1.74 [1.41-2.15],2.9085804246192935e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SELE,E-selectin,47267,128,2.56 [1.88-3.49],2.073318206846169e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SELP,P-selectin,46888,125,1.34 [1.03-1.75],0.0317998350994025
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SELPLG,P-selectin glycoprotein ligand 1,46626,123,2.67 [1.52-4.69],0.0006648442561344
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEMA3F,Semaphorin-3F,46694,125,5.81 [3.36-10.05],2.859834838809696e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEMA6C,Semaphorin-6C,39446,103,2.17 [1.38-3.42],0.0008402742546994
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEMA7A,Semaphorin-7A,47110,128,3.70 [2.90-4.73],8.999516508095154e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEPTIN8,Septin-8,40452,106,3.25 [2.41-4.38],9.473812572847786e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINA1,Alpha-1-antitrypsin,39907,103,9.36 [3.01-29.08],0.0001105971536456
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINA11,Serpin A11,47267,128,1.94 [1.33-2.83],0.0005791670340983
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINA3,Alpha-1-antichymotrypsin,40534,105,2.74 [1.14-6.59],0.0246043521323004
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINA4,Kallistatin,39950,105,2.43 [1.10-5.37],0.0289028727925319
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINA5,Plasma serine protease inhibitor,40093,105,1.67 [1.06-2.62],0.0260428492019248
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINA6,Corticosteroid-binding globulin,40679,105,7.79 [2.78-21.86],9.597233954250966e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINA9,Serpin A9,46259,123,1.68 [1.39-2.03],6.232356515053253e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPIND1,Heparin cofactor 2,40604,105,3.26 [1.73-6.15],0.0002667791115296
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINF1,Pigment epithelium-derived factor,40063,103,5.78 [3.65-9.16],8.420729300534589e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINH1,Serpin H1,39882,107,1.17 [1.02-1.35],0.0279149315147691
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SETMAR,Histone-lysine N-methyltransferase SETMAR,46184,124,0.57 [0.36-0.90],0.0152165502569419
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEZ6L,Seizure 6-like protein,46850,129,2.79 [1.67-4.66],8.454350165430061e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEZ6L2,Seizure 6-like protein 2,46483,124,2.59 [1.51-4.45],0.0005465461603266
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SF3B4,Splicing factor 3B subunit 4,46483,124,0.76 [0.60-0.95],0.0166905077368139
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SFRP1,Secreted frizzled-related protein 1,46180,124,1.87 [1.48-2.36],1.5351754518474834e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SFRP4,Secreted frizzled-related protein 4,39729,105,1.80 [1.14-2.85],0.0116590309366434
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SFTPD,Pulmonary surfactant-associated protein D,46694,125,1.47 [1.16-1.85],0.0012603195328954
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SGSH,N-sulphoglucosamine sulphohydrolase,39937,106,1.55 [1.14-2.09],0.0045894069415996
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,39312,102,1.34 [1.08-1.66],0.0082574257915704
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SH3BP1,SH3 domain-binding protein 1,40451,106,1.39 [1.02-1.91],0.0386913147018693
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SHBG,Sex hormone-binding globulin,40646,105,0.51 [0.37-0.70],4.210784042476123e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SHISA5,Protein shisa-5,40614,105,3.94 [3.22-4.83],2.45532145891206e-40
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIAE,Sialate O-acetylesterase,46769,129,1.77 [1.29-2.42],0.0003679018443167
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIGLEC1,Sialoadhesin,46900,124,3.93 [3.06-5.05],9.265345432444366e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIGLEC10,Sialic acid-binding Ig-like lectin 10,46626,123,3.18 [2.62-3.84],1.6775734302987308e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIGLEC5,Sialic acid-binding Ig-like lectin 5,46698,127,1.49 [1.23-1.79],3.226013850059104e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIGLEC6,Sialic acid-binding Ig-like lectin 6,47097,128,3.82 [2.86-5.11],1.4904591030689765e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIGLEC7,Sialic acid-binding Ig-like lectin 7,46694,125,5.04 [3.20-7.95],3.0353804411212e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIGLEC8,Sialic acid-binding Ig-like lectin 8,39538,103,2.86 [1.95-4.20],8.6546452179432e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIGLEC9,Sialic acid-binding Ig-like lectin 9,47028,128,2.80 [1.68-4.66],7.824375972750171e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,46815,125,2.26 [1.61-3.19],2.773733248043433e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIRPB1,Signal-regulatory protein beta-1,46594,123,3.72 [2.82-4.90],9.458379489028583e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIT1,Signaling threshold-regulating transmembrane adapter 1,45833,124,1.93 [1.47-2.54],2.250879379663376e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLAMF1,Signaling lymphocytic activation molecule,45833,124,2.30 [1.84-2.87],2.58029978789988e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLAMF6,SLAM family member 6,45615,120,2.73 [2.08-3.57],3.837177810321533e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLAMF7,SLAM family member 7,46626,123,2.05 [1.65-2.54],8.770887553536166e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLAMF8,SLAM family member 8,45615,120,3.47 [2.67-4.51],1.3778953044383376e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLC16A1,Monocarboxylate transporter 1,45638,124,1.42 [1.17-1.73],0.0004628067609054
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLC39A14,Zinc transporter ZIP14,45638,124,1.86 [1.35-2.57],0.0001744758246428
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLC39A5,Zinc transporter ZIP5,46626,123,1.60 [1.29-1.98],1.609685383820824e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,40451,106,1.51 [1.21-1.90],0.0002953286878751
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLIT2,Slit homolog 2 protein,45638,124,1.33 [1.04-1.70],0.0242960445722933
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLITRK2,SLIT and NTRK-like protein 2,47097,128,2.30 [1.58-3.35],1.316483582391399e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLITRK6,SLIT and NTRK-like protein 6,45838,124,1.80 [1.23-2.63],0.0023452998993539
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLMAP,Sarcolemmal membrane-associated protein,40451,106,1.59 [1.31-1.92],2.7193004811268007e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLURP1,Secreted Ly-6/uPAR-related protein 1,40321,104,1.56 [1.16-2.10],0.0036229912474968
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMOC1,SPARC-related modular calcium-binding protein 1,47097,128,3.34 [2.52-4.41],2.855080423844269e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMOC2,SPARC-related modular calcium-binding protein 2,46900,124,3.08 [2.26-4.21],1.471680073946873e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMPD1,Sphingomyelin phosphodiesterase,46888,125,2.14 [1.61-2.83],1.3889552480577066e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMTN,Smoothelin,40451,106,1.43 [1.21-1.70],3.770338334231046e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SNCG,Gamma-synuclein,46337,124,2.38 [1.90-2.97],2.325327866973604e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",39538,103,2.10 [1.45-3.06],9.359452893474512e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SNRPB2,U2 small nuclear ribonucleoprotein B'',40529,106,1.45 [1.13-1.86],0.003473209810023
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SNX2,Sorting nexin-2,40433,105,1.29 [1.07-1.56],0.0069175578233187
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SORBS1,Sorbin and SH3 domain-containing protein 1,40550,105,1.79 [1.45-2.22],7.278100384144366e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SORCS2,VPS10 domain-containing receptor SorCS2,45615,120,4.58 [3.38-6.20],9.082237553357108e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SORT1,Sortilin,46621,125,1.93 [1.31-2.86],0.0009809772525351
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SOST,Sclerostin,46621,125,1.68 [1.12-2.52],0.0128783840266049
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SOX9,Transcription factor SOX-9,39492,104,3.72 [1.90-7.26],0.0001192741656133
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,40550,105,1.58 [1.00-2.50],0.0491253353520416
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPINK1,Serine protease inhibitor Kazal-type 1,46698,127,4.06 [3.30-4.99],5.514794649644349e-40
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPINK2,Serine protease inhibitor Kazal-type 2,39729,105,1.84 [1.16-2.92],0.0099181517033361
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPINK4,Serine protease inhibitor Kazal-type 4,46626,123,2.90 [2.50-3.35],3.477685322027541e-46
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPINT1,Kunitz-type protease inhibitor 1,46543,126,3.96 [2.82-5.55],1.8274676604863285e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPINT2,Kunitz-type protease inhibitor 2,46900,124,3.63 [2.54-5.19],1.492392495198946e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPOCK1,Testican-1,46337,124,0.56 [0.39-0.80],0.001538812903426
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPON1,Spondin-1,46745,123,3.42 [2.83-4.13],5.225857399544051e-37
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPON2,Spondin-2,46468,125,6.72 [4.66-9.70],2.3132708986205488e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPP1,Osteopontin,47191,127,1.82 [1.33-2.49],0.0001677713218249
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",39446,103,1.54 [1.06-2.24],0.025095707310617
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPRR3,Small proline-rich protein 3,40529,106,1.52 [1.17-1.97],0.0018237986543706
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPTLC1,Serine palmitoyltransferase 1,40529,106,1.44 [1.03-2.03],0.034641196667978
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SRPX,Sushi repeat-containing protein SRPX,40628,107,2.81 [1.75-4.52],2.0289404203812512e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,46888,125,1.84 [1.28-2.64],0.0009498449961544
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",46483,124,1.84 [1.42-2.37],2.839229194726575e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",47267,128,2.72 [2.10-3.51],2.0776895015810683e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STAB2,Stabilin-2,40614,105,3.21 [1.78-5.77],9.919924974762224e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STAT2,Signal transducer and activator of transcription 2,39446,103,1.31 [1.04-1.66],0.0211168742689812
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STC1,Stanniocalcin-1,47117,128,2.51 [1.93-3.26],4.427475679426792e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STC2,Stanniocalcin-2,46637,127,4.56 [2.44-8.53],2.00805841578198e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STX16,Syntaxin-16,45615,120,1.41 [1.11-1.78],0.004406046209826
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STX4,Syntaxin-4,46483,124,1.48 [1.22-1.79],5.912184300320737e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STX6,Syntaxin-6,45615,120,1.36 [1.09-1.68],0.0056490305342543
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STX7,Syntaxin-7,39446,103,2.02 [1.38-2.95],0.0002954180079424
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STX8,Syntaxin-8,46626,123,1.60 [1.19-2.13],0.0016035449404356
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SULT2A1,Bile salt sulfotransferase,46626,123,1.56 [1.29-1.89],4.885319281883126e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,47117,128,1.60 [1.17-2.20],0.0034051410731164
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SUOX,"Sulfite oxidase, mitochondrial",40550,105,1.56 [1.21-2.01],0.000673067003468
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SUSD2,Sushi domain-containing protein 2,46698,127,2.54 [1.69-3.84],8.512400203088795e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SUSD4,Sushi domain-containing protein 4,40433,105,1.76 [1.24-2.51],0.0016260108334264
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SV2A,Synaptic vesicle glycoprotein 2A,39492,104,1.35 [1.07-1.72],0.0131374167495804
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SYTL4,Synaptotagmin-like protein 4,40628,107,1.31 [1.05-1.63],0.018023182257116
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TACSTD2,Tumor-associated calcium signal transducer 2,41390,114,2.90 [2.17-3.86],4.1430315943239123e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TAFA5,Chemokine-like protein TAFA-5,46483,124,3.04 [2.23-4.14],2.3323984530619152e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TAX1BP1,Tax1-binding protein 1,40529,106,1.53 [1.18-1.99],0.0014779479966527
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TCL1A,T-cell leukemia/lymphoma protein 1A,46265,124,0.71 [0.61-0.82],6.229891156161402e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TCN2,Transcobalamin-2,47191,127,3.66 [2.77-4.84],7.227464565882062e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TCOF1,Treacle protein,40628,107,2.16 [1.55-3.00],5.378033023092746e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TEK,Angiopoietin-1 receptor,46850,129,4.57 [2.35-8.88],7.345972296872397e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TF,Serotransferrin,40679,105,2.57 [1.10-6.01],0.0299111950672802
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TFF1,Trefoil factor 1,46468,127,2.12 [1.84-2.44],7.730495664436878e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TFF2,Trefoil factor 2,46823,124,3.61 [2.94-4.42],5.009917292294216e-35
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TFF3,Trefoil factor 3,46671,125,2.52 [2.21-2.87],2.3504508954560987e-43
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TFPI2,Tissue factor pathway inhibitor 2,46703,129,1.54 [1.26-1.88],2.2006884551169327e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TFRC,Transferrin receptor protein 1,46889,125,2.26 [1.61-3.17],2.563347684140013e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TGFA,Protransforming growth factor alpha,46626,123,2.86 [2.24-3.64],2.4360451165269934e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TGFB1,Transforming growth factor beta-1 proprotein,47133,127,2.66 [2.07-3.41],2.126980561162624e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TGFBR1,TGF-beta receptor type-1,39446,103,2.56 [1.70-3.85],6.047707965862239e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TGFBR2,TGF-beta receptor type-2,46850,129,3.97 [3.17-4.96],1.1751895057134752e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TGFBR3,Transforming growth factor beta receptor type 3,47267,128,1.82 [1.10-3.02],0.0197236484550741
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TGM2,Protein-glutamine gamma-glutamyltransferase 2,46622,125,0.78 [0.63-0.95],0.016225629226806
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TGOLN2,Trans-Golgi network integral membrane protein 2,40646,105,5.08 [2.87-8.99],2.348003664083369e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,THBD,Thrombomodulin,46694,125,4.01 [2.87-5.60],3.8303753612966574e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,THBS2,Thrombospondin-2,46698,127,4.17 [3.31-5.27],2.204415320635912e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,THBS4,Thrombospondin-4,46731,125,1.71 [1.24-2.37],0.0012103677812787
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,THY1,Thy-1 membrane glycoprotein,47117,128,3.72 [2.39-5.81],6.359265273873605e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TIE1,Tyrosine-protein kinase receptor Tie-1,47267,128,1.66 [1.04-2.65],0.0325530191796865
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,39882,107,2.37 [1.78-3.16],3.4046214648568597e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,40628,107,1.50 [1.00-2.26],0.0498075750214141
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TIMP1,Metalloproteinase inhibitor 1,46208,125,5.61 [4.30-7.32],5.40986567741736e-37
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TIMP4,Metalloproteinase inhibitor 4,46698,127,1.61 [1.13-2.28],0.0077020780907653
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TINAGL1,Tubulointerstitial nephritis antigen-like,46544,125,6.52 [3.34-12.75],4.0524498684460537e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TK1,"Thymidine kinase, cytosolic",39882,107,1.42 [1.03-1.97],0.0329078864195161
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TLR1,Toll-like receptor 1,39446,103,4.01 [2.47-6.50],1.9003466710810195e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TLR2,Toll-like receptor 2,39882,107,2.21 [1.05-4.62],0.0359854139305567
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TLR3,Toll-like receptor 3,47210,127,1.33 [1.01-1.73],0.0389890032514865
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TLR4,Toll-like receptor 4,39446,103,2.34 [1.35-4.06],0.0023840753242849
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TMOD4,Tropomodulin-4,39172,104,1.82 [1.23-2.67],0.0024342869120639
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TMPRSS11D,Transmembrane protease serine 11D,40452,106,2.06 [1.46-2.89],3.173684751702711e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TMPRSS15,Enteropeptidase,46483,124,1.86 [1.56-2.22],5.405282937865492e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TMSB10,Thymosin beta-10,46698,127,1.46 [1.19-1.80],0.0003553155040839
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNC,Tenascin,46888,125,1.54 [1.12-2.10],0.0073259026043017
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNF,Tumor necrosis factor,45764,123,1.91 [1.58-2.31],2.988141429972154e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,40451,106,1.58 [1.15-2.17],0.0048355867697312
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,46337,124,3.65 [3.05-4.36],9.306712372430582e-46
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,46337,124,20.80 [8.03-53.90],4.139852312164327e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,46805,126,1.55 [1.10-2.18],0.012228731826079
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,47210,127,5.27 [4.16-6.69],7.531153046206237e-43
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,46670,123,6.12 [4.41-8.50],2.31856226664372e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,46850,129,5.59 [4.45-7.04],4.2762470858904015e-49
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,46745,123,2.43 [2.01-2.93],3.6165407800667934e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,45833,124,1.47 [1.06-2.05],0.0209870908036482
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,46745,123,7.46 [5.49-10.13],7.342215424044746e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,39729,105,2.28 [1.48-3.50],0.0001727513937982
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,47097,128,3.81 [2.89-5.03],3.846258785461235e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,46698,127,7.07 [5.44-9.20],2.240241999527533e-48
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,46698,127,2.23 [1.95-2.55],6.22432594718474e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,47117,128,4.26 [2.87-6.31],5.222802918406381e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,47133,127,4.14 [3.24-5.29],1.0499865843381182e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,46337,124,2.11 [1.76-2.52],2.875213957396122e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,47117,128,2.47 [1.89-3.22],2.5799913002922328e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,46337,124,2.51 [2.15-2.93],2.2865178929852064e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFSF10,Tumor necrosis factor ligand superfamily member 10,47210,127,0.63 [0.45-0.90],0.010657363840231
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFSF11,Tumor necrosis factor ligand superfamily member 11,46626,123,0.65 [0.50-0.85],0.0016508447668861
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFSF12,Tumor necrosis factor ligand superfamily member 12,47210,127,0.31 [0.18-0.53],1.5702906441617606e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFSF13,Tumor necrosis factor ligand superfamily member 13,46900,124,5.91 [3.73-9.38],4.398274268135295e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,47187,128,2.41 [1.54-3.77],0.0001197772455871
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFSF8,Tumor necrosis factor ligand superfamily member 8,40614,105,3.52 [2.48-4.99],1.9523878616627986e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNN,Tenascin-N,40614,105,2.32 [1.52-3.54],9.096059094364352e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNNI3,"Troponin I, cardiac muscle",45838,124,1.30 [1.06-1.59],0.013414419412313
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNXB,Tenascin-X,46698,127,0.36 [0.21-0.61],0.0001517414184437
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,40628,107,1.46 [1.19-1.80],0.0003125839088833
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TOP2B,DNA topoisomerase 2-beta,39446,103,1.31 [1.05-1.64],0.0173881457090784
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TP53BP1,TP53-binding protein 1,39446,103,1.41 [1.14-1.75],0.0015542948510736
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TPK1,Thiamin pyrophosphokinase 1,40628,107,0.50 [0.25-0.98],0.044188976012649
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TPMT,Thiopurine S-methyltransferase,45615,120,0.73 [0.57-0.92],0.0089913593283962
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TPP1,Tripeptidyl-peptidase 1,46359,123,1.97 [1.55-2.52],5.2129115527836016e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TPPP3,Tubulin polymerization-promoting protein family member 3,45638,124,0.53 [0.32-0.87],0.0113472978484476
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TPR,Nucleoprotein TPR,39283,102,1.42 [1.08-1.86],0.0109376704387064
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TPSAB1,Tryptase alpha/beta-1,47133,127,1.43 [1.06-1.94],0.0210948877619797
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TPSD1,Tryptase delta,40550,105,1.61 [1.17-2.21],0.0032730757727919
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TREH,Trehalase,40614,105,1.78 [1.36-2.32],2.8604271792483592e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TREM2,Triggering receptor expressed on myeloid cells 2,46670,123,2.30 [1.79-2.96],7.353550209291712e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TREML2,Trem-like transcript 2 protein,46698,127,1.70 [1.14-2.55],0.0099245153285242
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TRIAP1,TP53-regulated inhibitor of apoptosis 1,47097,128,1.50 [1.19-1.90],0.000714547641492
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TRIM58,E3 ubiquitin-protein ligase TRIM58,40433,105,1.23 [1.00-1.52],0.0481645205816691
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TSC22D1,TSC22 domain family protein 1,40550,105,1.32 [1.03-1.69],0.029140228532144
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TSHB,Thyrotropin subunit beta,46694,125,0.76 [0.62-0.94],0.0125175322622049
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TSPAN8,Tetraspanin-8,40451,106,1.25 [1.03-1.51],0.0214316999165259
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TTN,Titin,39283,102,1.40 [1.12-1.75],0.0035163975370406
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TTR,Transthyretin,40233,105,0.40 [0.20-0.79],0.0087424621781658
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TXLNA,Alpha-taxilin,46337,124,1.26 [1.05-1.52],0.012618689704295
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TXNDC15,Thioredoxin domain-containing protein 15,46850,129,2.21 [1.30-3.74],0.0034057131577865
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TXNDC5,Thioredoxin domain-containing protein 5,47117,128,1.53 [1.24-1.89],8.078910319589946e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TYRO3,Tyrosine-protein kinase receptor TYRO3,46694,125,2.16 [1.24-3.75],0.0062890308105598
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",39446,103,1.73 [1.26-2.37],0.0006126974983476
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UBAC1,Ubiquitin-associated domain-containing protein 1,46483,124,0.48 [0.30-0.78],0.0027151152856964
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,40628,107,1.44 [1.08-1.92],0.0125432115955318
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UGDH,UDP-glucose 6-dehydrogenase,39283,102,1.19 [1.02-1.39],0.0307208488293583
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ULBP2,UL16-binding protein 2,46337,124,4.26 [3.24-5.59],2.621435036547129e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UMOD,Uromodulin,47123,127,0.35 [0.28-0.43],1.476468708978806e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UNC5D,Netrin receptor UNC5D,39446,103,2.22 [1.22-4.06],0.0093102165760221
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UPB1,Beta-ureidopropionase,40628,107,1.37 [1.14-1.64],0.0005705886054268
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,USP28,Ubiquitin carboxyl-terminal hydrolase 28,40529,106,1.91 [1.45-2.53],5.462025165110438e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VAMP5,Vesicle-associated membrane protein 5,45838,124,1.41 [1.14-1.75],0.0017557677162438
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VASN,Vasorin,45973,123,2.73 [1.57-4.76],0.000378637428304
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VCAM1,Vascular cell adhesion protein 1,46810,125,7.47 [5.22-10.69],3.427636042857334e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VCAN,Versican core protein,47117,128,1.76 [1.04-2.98],0.0339855263640144
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VEGFA,Vascular endothelial growth factor A,47060,127,1.81 [1.43-2.30],1.1635837450052776e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VEGFB,Vascular endothelial growth factor B,39446,103,4.74 [2.78-8.10],1.1841625361248325e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VEGFD,Vascular endothelial growth factor D,47136,127,4.44 [3.04-6.48],1.1937083294367418e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VGF,Neurosecretory protein VGF,40550,105,2.30 [1.37-3.88],0.0017536127118747
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VMO1,Vitelline membrane outer layer protein 1 homolog,46483,124,1.97 [1.53-2.53],1.2118257139848126e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VNN2,Vascular non-inflammatory molecule 2,46483,124,1.59 [1.09-2.31],0.0148713610317669
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VSIG10,V-set and immunoglobulin domain-containing protein 10,40433,105,1.57 [1.03-2.42],0.0380257376300949
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,39283,102,1.71 [1.11-2.63],0.014746149744413
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VSIG2,V-set and immunoglobulin domain-containing protein 2,40433,105,2.72 [2.25-3.30],1.3354440395073432e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VSIG4,V-set and immunoglobulin domain-containing protein 4,46637,127,4.99 [3.95-6.30],3.023807196905699e-41
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,46624,125,1.39 [1.12-1.73],0.0029042525206393
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VSTM1,V-set and transmembrane domain-containing protein 1,45638,124,1.50 [1.16-1.95],0.0018519606945551
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,45838,124,1.45 [1.19-1.75],0.0001693121562339
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VTCN1,V-set domain-containing T-cell activation inhibitor 1,45615,120,2.05 [1.38-3.05],0.0004164010223231
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,39729,105,1.51 [1.12-2.03],0.0061345480026563
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VWA1,von Willebrand factor A domain-containing protein 1,47029,128,1.65 [1.14-2.37],0.0077850859269093
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VWC2,Brorin,46182,123,3.09 [2.15-4.44],1.2209882404652014e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VWF,von Willebrand factor,47267,128,1.53 [1.24-1.88],5.7440526913156525e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WASHC3,WASH complex subunit 3,40529,106,1.39 [1.12-1.72],0.0031039781975392
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WFDC1,WAP four-disulfide core domain protein 1,39616,104,1.62 [1.35-1.95],1.6061466720632925e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WFDC12,WAP four-disulfide core domain protein 12,47019,128,1.49 [1.19-1.88],0.0006122638612391
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WFDC2,WAP four-disulfide core domain protein 2,44329,123,3.63 [2.98-4.43],2.2493352838036763e-37
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",46184,124,0.35 [0.24-0.52],7.593737239105597e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WIF1,Wnt inhibitory factor 1,47097,128,0.31 [0.19-0.50],1.3937612455034468e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WNT9A,Protein Wnt-9a,45833,124,3.86 [2.93-5.08],6.71364088512291e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,XCL1,Lymphotactin,47097,128,1.71 [1.41-2.08],6.86465977762911e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,XG,Glycoprotein Xg,47042,128,3.46 [2.57-4.67],3.692390818685171e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,XIAP,E3 ubiquitin-protein ligase XIAP,39446,103,1.39 [1.03-1.89],0.0331785176550242
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,XPNPEP2,Xaa-Pro aminopeptidase 2,46850,129,0.72 [0.63-0.82],1.481910461976734e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,YAP1,Transcriptional coactivator YAP1,40529,106,4.63 [3.55-6.05],2.6852223754858746e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,YES1,Tyrosine-protein kinase Yes,46483,124,1.19 [1.03-1.37],0.0162776293268094
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,YOD1,Ubiquitin thioesterase OTU1,39283,102,0.73 [0.53-0.99],0.0448950952154161
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ZBTB16,Zinc finger and BTB domain-containing protein 16,45615,120,1.34 [1.10-1.64],0.0037575900169624
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ZBTB17,Zinc finger and BTB domain-containing protein 17,45838,124,1.44 [1.12-1.87],0.0051289252392811
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ZHX2,Zinc fingers and homeoboxes protein 2,40529,106,1.52 [1.03-2.26],0.0360255720981998
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ZNRD2,Protein ZNRD2,40451,106,1.93 [1.55-2.40],4.610526896263596e-09
